RESULT_COUNT: 460,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
JAZZ,JAZZ:UW,BBG000G9DVF3,ImmunoGen to Push Leukemia Candidate into Phase I Trial,2017-10-18 00:49:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qUhZLK7IlUA/immunogen-to-push-leukemia-candidate-into-phase-i-trial-cm861047,ImmunoGen Inc IMGN announced that it is planning to move its leukemia candidate IMGN632 into phase I study before the year end The company said that the FDA has completed the safety review of its investigational new drug IND application for IMGN632 filed in mid September for
JAZZ,JAZZ:UW,BBG000G9DVF3,All that Jazz: Why this Palo Alto drug maker is growing,2017-10-13 14:20:11 +0000,http://finance.yahoo.com/r/2d5ac51c-3f8e-324e-babb-71c7fee4e036/jazz-pharmaceuticals-leukemia-narcolepsy-vyxeos.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Jazz Pharmaceuticals plc is feeling the rhythm of growth.  Fresh off winning Food and Drug Administration approval of a leukemia-fighting drug, the Ireland-domiciled, Palo Alto-based drug developer (JAZZ) soon will move into a new, 98,000-square-foot office building in Stanford Research Park, which it agreed to lease in early 2015 for $66 per square foot.  Last month, it said it would pay more than $74 a square foot for a 100,000-square-foot structure on the site of its current home just down the street."
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETFs with exposure to Jazz Pharmaceuticals Plc : October 11, 2017",2017-10-11 15:42:42 +0000,http://finance.yahoo.com/r/80e0761e-322b-35ff-ad3c-4b39632d0dc0/etfs-with-exposure-to-jazz-pharmaceuticals-plc-october-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Jazz Pharmaceuticals Plc Here are 5 ETFs with the largest exposure to JAZZ-US. Comparing the performance and risk of Jazz Pharmaceuticals Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,Notable Two Hundred Day Moving Average Cross - JAZZ,2017-10-10 17:12:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CDm-hAKaFjs/notable-two-hundred-day-moving-average-cross-jazz-cm857657,In trading on Tuesday shares of Jazz Pharmaceuticals plc Symbol JAZZ crossed below their 200 day moving average of 143 91 changing hands as low as 143 50 per share Jazz Pharmaceuticals plc shares are currently trading down about 1 1 on the day The chart below shows the one
JAZZ,JAZZ:UW,BBG000G9DVF3,Genocea Biosciences (GNCA) Jumps: Stock Rises 24.8%,2017-10-06 14:46:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fQMVfMhyt3Q/genocea-biosciences-gnca-jumps-stock-rises-248-cm856191,Genocea Biosciences Inc GNCA was a big mover last session as the company saw its shares rise almost 25 on the day The move came on solid volume too with far more shares changing hands than in a normal session This stock trading within a volatile range of 1 19 5 59 in the past one
JAZZ,JAZZ:UW,BBG000G9DVF3,Genocea Biosciences (GNCA) Jumps: Stock Rises 24.8%,2017-10-06 12:35:12 +0000,https://finance.yahoo.com/news/genocea-biosciences-gnca-jumps-stock-123512026.html?.tsrc=rss,"Genocea Biosciences (GNCA) was a big mover last session, as the company saw its shares rise almost 25% on the day amid huge volumes."
JAZZ,JAZZ:UW,BBG000G9DVF3,Rigel Pharmaceuticals (RIGL) in Focus: Stock Moves 12.1% Higher,2017-10-05 14:54:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fnOWJbKrQ0w/rigel-pharmaceuticals-rigl-in-focus-stock-moves-121-higher-cm855668,Rigel Pharmaceuticals Inc RIGL was a big mover last session as the company saw its shares rise more than 12 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now
JAZZ,JAZZ:UW,BBG000G9DVF3,Synergy Pharmaceuticals (SGYP) Surges: Stock Moves 12.1% Higher,2017-10-03 13:51:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OYDfgtXbeCQ/synergy-pharmaceuticals-sgyp-surges-stock-moves-121-higher-cm854464,Synergy Pharmaceuticals Inc SGYP was a big mover last session as the company saw its shares rise more than 12 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : October 3, 2017",2017-10-03 12:17:44 +0000,http://finance.yahoo.com/r/279763f5-8426-30d3-af20-f5f73ba78513/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bullish-manner-jazz-us-october-3-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETFs with exposure to Jazz Pharmaceuticals Plc : September 25, 2017",2017-09-25 14:40:34 +0000,http://finance.yahoo.com/r/9c99e1df-c58d-335a-86ef-eb39bf7d0c37/etfs-with-exposure-to-jazz-pharmaceuticals-plc-september-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Jazz Pharmaceuticals Plc Here are 5 ETFs with the largest exposure to JAZZ-US. Comparing the performance and risk of Jazz Pharmaceuticals Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Stocks That Are Absurdly Cheap Right Now,2017-09-20 12:01:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/otYS-mfHr5I/3-stocks-that-are-absurdly-cheap-right-now-cm848164,The S amp P 500 160 is within spitting distance of its all time high but that doesn t mean every stock is overpriced In fact we asked a team of investors to highlight a stock that they think is trading at a bargain bin price at the moment They highlighted Best Buy NYSE
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Stocks That Are Absurdly Cheap Right Now,2017-09-20 10:30:00 +0000,http://finance.yahoo.com/r/4eaf5cb6-9ae3-3e12-bf80-7d881470585f/3-stocks-that-are-absurdly-cheap-right-now.aspx?yptr=yahoo&.tsrc=rss,Looking for value in today&apos;s pricy market? These three stocks fit the bill.
JAZZ,JAZZ:UW,BBG000G9DVF3,"Is ImmunoGen Running Out of Steam, or Taking a Breather?",2017-09-16 16:36:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5cmsL-MKiD0/is-immunogen-running-out-of-steam-or-taking-a-breather-cm846731,There s good news and bad news for ImmunoGen NASDAQ IMGN shareholders The good news is that the biotech stock is up more than 230 so far in 2017 The bad news Shares have dropped nearly 20 in the last couple of weeks Certainly ImmunoGen s tremendous performance this
JAZZ,JAZZ:UW,BBG000G9DVF3,See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.,2017-09-15 12:04:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120416253.html?.tsrc=rss,Jazz Pharmaceuticals PLC NASDAQ/NGS:JAZZ
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETFs with exposure to Jazz Pharmaceuticals Plc : September 14, 2017",2017-09-14 22:28:57 +0000,http://finance.yahoo.com/r/ce395f87-dfa9-39b4-a35b-eefd8cf83923/etfs-with-exposure-to-jazz-pharmaceuticals-plc-september-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Jazz Pharmaceuticals Plc Here are 5 ETFs with the largest exposure to JAZZ-US. Comparing the performance and risk of Jazz Pharmaceuticals Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.,2017-09-14 12:04:30 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120430138.html?.tsrc=rss,Jazz Pharmaceuticals PLC NASDAQ/NGS:JAZZ
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Pharma/Biotech Sector Bargains for a Healthy Portfolio,2017-09-13 17:36:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k2XMQxazGSY/3-pharmabiotech-sector-bargains-for-a-healthy-portfolio-cm845231,After a lackluster performance in 2016 the drug biotech sector has shown promise since the beginning of 2017 With no major announcement related to drug pricing control since Trump s election as President investors are breathing a sigh of relief Drug pricing controversy was one the major
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017",2017-09-13 15:31:58 +0000,http://finance.yahoo.com/r/f73c983c-99ae-3db1-a59d-6de9b7e6e715/jazz-pharmaceuticals-plc-jazz-us-earnings-analysis-q2-2017-by-the-numbers-september-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Jazz Pharmaceuticals Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Jazz Pharmaceuticals Plc – Endo International Plc, Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries Limited Sponsored ADR, Paratek Pharmaceuticals Inc, AmerisourceBergen Corporation and Novartis AG Sponsored ADR (ENDP-US, ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Pharma/Biotech Sector Bargains for a Healthy Portfolio,2017-09-13 15:25:03 +0000,https://finance.yahoo.com/news/3-pharma-biotech-sector-bargains-152503838.html?.tsrc=rss,"The biotech sector has turned around after its dismal performance in 2016 as uncertainty surrounding drug pricing control subsides. A few stocks are however still undervalued, which may gain going ahead."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc – Value Analysis (NASDAQ:JAZZ) : September 12, 2017",2017-09-12 23:38:45 +0000,http://finance.yahoo.com/r/3edffc99-4d69-3410-a857-9a8e69412198/jazz-pharmaceuticals-plc-value-analysis-nasdaqjazz-september-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Jazz Pharmaceuticals Plc a score of 91. Our analysis is based on comparing Jazz Pharmaceuticals Plc with the following peers – Endo International Plc, Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries Limited Sponsored ADR, Paratek Pharmaceuticals Inc, AmerisourceBergen Corporation and Novartis AG Sponsored ADR (ENDP-US, VRX-US, TEVA-US, ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,Fortune Magazine Names Jazz Pharmaceuticals 78th Fastest Growing Company for 2017,2017-09-12 12:30:00 +0000,https://finance.yahoo.com/news/fortune-magazine-names-jazz-pharmaceuticals-123000269.html?.tsrc=rss,"DUBLIN, Sept. 12, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the company was named to Fortune magazine's list of fastest growing companies for 2017.  In Fortune's annual rankings, Jazz was named the 78th fastest growing company.  ""We are honored to be recognized with some of the most innovative companies in the world,"" said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : September 11, 2017",2017-09-11 13:02:11 +0000,http://finance.yahoo.com/r/47bfcc34-910f-307b-a4f5-c19c756a5f1f/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bullish-manner-jazz-us-september-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,Where Jazz Pharmaceuticals’ Erwinaze and Prialt Are Positioned after 2Q17,2017-09-11 11:36:36 +0000,http://finance.yahoo.com/r/eb84db8c-66c2-33bb-9a2c-14dfeca81975/where-jazz-pharmaceuticals-erwinaze-and-prialt-are-positioned-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Jazz Pharmaceuticals’ (JAZZ) Erwinaze generated revenues of ~$49 million, which represents a ~1% fall YoY and a ~4% fall QoQ."
JAZZ,JAZZ:UW,BBG000G9DVF3,How Is Jazz’s Defitelio Positioned after 2Q17?,2017-09-08 14:36:54 +0000,http://finance.yahoo.com/r/578c40ac-ca74-3298-957c-fa684a078f1b/how-is-jazzs-defitelio-positioned-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Jazz Pharmaceuticals’ (JAZZ) Defitelio generated revenues of ~$30 million, which represents a ~10% fall YoY and a ~17% fall QoQ."
JAZZ,JAZZ:UW,BBG000G9DVF3,This Could Drive Jazz Pharmaceuticals’ Revenue Growth,2017-09-08 13:07:17 +0000,http://finance.yahoo.com/r/58e9cd47-7847-3c44-bb26-e3109001b924/this-could-drive-jazz-pharmaceuticals-revenue-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Jazz Pharmaceuticals’ (JAZZ) Xyrem generated revenues of ~$298 million, which represents ~6% growth YoY and ~10% growth QoQ."
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Jazz Pharmaceuticals’ Vyxeos Could Boost Revenue Growth in 2018,2017-09-08 11:37:38 +0000,http://finance.yahoo.com/r/59ac3471-512d-348d-87ff-97e996d44b86/why-jazz-pharmaceuticals-vyxeos-could-boost-revenue-growth-in-2018?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In August 2017, JAZZ's Vyxeos liposome injection for the treatment of adult individuals with rapidly progressing or life t-AML received FDA approval."
JAZZ,JAZZ:UW,BBG000G9DVF3,Behind Jazz’s Strategic Collaboration with ImmunoGen,2017-09-07 20:35:58 +0000,http://finance.yahoo.com/r/7f571e57-1586-3906-8707-d6e69c547070/behind-jazzs-strategic-collaboration-with-immunogen?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In August 2017, Jazz Pharmaceuticals (JAZZ) and ImmunoGen (IMGN) entered into a strategic collaboration and option agreement."
JAZZ,JAZZ:UW,BBG000G9DVF3,How Did Jazz Pharmaceuticals Perform in 1H17?,2017-09-07 19:06:06 +0000,http://finance.yahoo.com/r/00437ba2-5a67-3fed-bb08-bd0eaa879b0b/how-did-jazz-pharmaceuticals-perform-in-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Jazz Pharmaceuticals (JAZZ) generated revenues of ~$570 million, which represents ~7% growth on a YoY (year-over-year) basis."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals on the Street: Analysts’ Recommendations after 1H17,2017-09-07 17:29:23 +0000,http://finance.yahoo.com/r/97b0e62f-b5ab-3f00-9307-f03e998962e9/jazz-pharmaceuticals-on-the-street-analysts-recommendations-after-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In July 2017, Jazz Pharmaceuticals entered into a license agreement with XL-Protein GmbH involving products using XL-Protein’s PASylation technology."
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Key Things You Should Watch With Jazz Pharmaceuticals,2017-09-07 12:51:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CJVpHZbarrw/5-key-things-you-should-watch-with-jazz-pharmaceuticals-cm842077,It s been a great year for Jazz Pharmaceuticals NASDAQ JAZZ shareholders so far The biotech stock is up more than 35 year to date However most of those gains were made in the first quarter thanks to positive clinical results Over the last five months Jazz stock
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Key Things You Should Watch With Jazz Pharmaceuticals,2017-09-07 11:38:00 +0000,http://finance.yahoo.com/r/909b11b6-3a2e-3ec8-b526-97d99d6505cd/5-key-things-you-should-watch-with-jazz-pharmaceut.aspx?yptr=yahoo&.tsrc=rss,Jazz Pharmaceuticals&apos; CEO says that these developments are what investors should closely monitor in the months ahead.
JAZZ,JAZZ:UW,BBG000G9DVF3,New Drugs Approved In August,2017-09-07 05:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZoP1iaTzo4w/new-drugs-approved-in-august-20170907-00189,New Drugs Approved In August
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals, O'Reilly Automotive and Tesla highlighted as Zacks Bull and Bear of the Day",2017-09-05 16:52:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W2eawuI1cFY/jazz-pharmaceuticals-oreilly-automotive-and-tesla-highlighted-as-zacks-bull-and-bear-of-the-day-cm841117,For Immediate Release Chicago IL September 5 2017 Zacks Equity Research Jazz Pharmaceuticals NASDAQ 160 JAZZ Free Report as the Bull of the Day O Reilly Automotive NASDAQ 160 ORLY Free Report as the Bear of the Day In addition Zacks Equity Research provides
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals, O&apos;Reilly Automotive and Tesla highlighted as Zacks Bull and Bear of the Day",2017-09-05 14:19:02 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-o-apos-reilly-141902421.html?.tsrc=rss,"Jazz Pharmaceuticals, O&apos;Reilly Automotive and Tesla highlighted as Zacks Bull and Bear of the Day"
JAZZ,JAZZ:UW,BBG000G9DVF3,See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.,2017-09-05 12:04:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120456605.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
JAZZ,JAZZ:UW,BBG000G9DVF3,Bull of the Day: Jazz Pharmaceuticals (JAZZ),2017-09-05 11:50:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1xXegWRcc-8/bull-of-the-day-jazz-pharmaceuticals-jazz-cm840868,Jazz Pharmaceuticals JAZZ is a 9 billion drug company focused on developing and commercializing innovative products to meet unmet medical needs in neurology psychiatry and oncology On August 8 Jazz reported a weaker than expected quarter and guidance which knocked the shares down
JAZZ,JAZZ:UW,BBG000G9DVF3,Bull of the Day: Jazz Pharmaceuticals (JAZZ),2017-09-05 08:00:08 +0000,https://finance.yahoo.com/news/bull-day-jazz-pharmaceuticals-jazz-080008538.html?.tsrc=rss,Bull of the Day: Jazz Pharmaceuticals (JAZZ)
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Completion of Offering and Exercise in Full of Initial Purchasers' Option to Purchase Additional 1.50% Exchangeable Senior Notes due 2024,2017-09-01 16:36:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-completion-offering-163600777.html?.tsrc=rss,"Jazz Pharmaceuticals used the net proceeds from the sale of the initial notes, together with cash on hand, to repay $500 million of outstanding borrowings under its revolving credit facility on August 28, 2017.  Jazz Pharmaceuticals intends to use the net proceeds from the sale of the additional notes for general corporate purposes, including potential business development activities."
JAZZ,JAZZ:UW,BBG000G9DVF3,Ligand Pharmaceuticals Focuses on Increasing Returns for Shareholders,2017-09-01 11:36:41 +0000,http://finance.yahoo.com/r/47c644c8-feee-30ec-84c9-4d56b6218e1a/ligand-pharmaceuticals-focused-increasing-returns-shareholders-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Ligand Pharmaceuticals has developed a product portfolio that spans more than 700 patents offering varying degrees of protection to the assets.
JAZZ,JAZZ:UW,BBG000G9DVF3,[$$] Former Pharma Company CPA Pleads Guilty in Insider-Trading Scheme,2017-09-01 00:07:49 +0000,http://finance.yahoo.com/r/dbf674b5-380c-3ff0-ad75-3108fdc4fb45/former-pharma-company-cpa-two-others-plead-guilty-in-insider-trading-scheme-1504212026?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,A former Celator Pharmaceuticals accountant and two other men pleaded guilty to federal charges for their roles in an insider-trading scheme involving nonpublic information on Celator
JAZZ,JAZZ:UW,BBG000G9DVF3,"Former Celator Pharmaceuticals accountant, three others charged with insider trading",2017-08-31 17:31:56 +0000,http://finance.yahoo.com/r/0d43a75b-4789-3ba0-84d8-ef4c2eb700a0/Story.aspx?guid=E9EB9075-618C-4820-B754-E3C5A2870B0D&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The Securities and Exchange Commission charged an accountant and three others with trading on confidential market-moving news about Celator Pharmaceuticals Inc., a New Jersey-based pharmaceutical company ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Zacks.com featured highlights include Lantheus Holdings, Jazz Pharmaceuticals, Gray Television, Aetna and Uniti Group",2017-08-31 16:50:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XxaQ2Dn2R6o/zackscom-featured-highlights-include-lantheus-holdings-jazz-pharmaceuticals-gray-television-aetna-and-uniti-group-cm839772,For Immediate Release Chicago IL August 31 2017 Stocks in this week s article include Lantheus Holdings Inc NASDAQ 160 LNTH Free Report Jazz Pharmaceuticals Public Limited Company NASDAQ 160 JAZZ Free Report Gray Television Inc NYSE 160 GTN Free
JAZZ,JAZZ:UW,BBG000G9DVF3,"Zacks.com featured highlights include Lantheus Holdings, Jazz Pharmaceuticals, Gray Television, Aetna and Uniti Group",2017-08-31 15:07:03 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-lantheus-150703101.html?.tsrc=rss,"Zacks.com featured highlights include Lantheus Holdings, Jazz Pharmaceuticals, Gray Television, Aetna and Uniti Group"
JAZZ,JAZZ:UW,BBG000G9DVF3,Technology Platforms and Research Programs Drive LGND’s Partnerships,2017-08-31 14:36:54 +0000,http://finance.yahoo.com/r/a65c2933-363a-3c61-8535-03c1949a40b3/technology-platforms-research-programs-drive-ligand-pharmaceuticals-partnerships-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Ligand Pharmaceuticals (LGND) has entered multiple fully funded partnerships by licensing its technology platforms such as OmniAb, Captisol, LTP Technology, and SUREtechnology Platform."
JAZZ,JAZZ:UW,BBG000G9DVF3,Featured Company News - Jazz Pharma to Partner with ImmunoGen for the Development and Commercialization of Antibody-Drug Conjugate Products,2017-08-31 11:50:00 +0000,https://finance.yahoo.com/news/featured-company-news-jazz-pharma-115000237.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / August 31, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) (""Jazz""), following ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Investors Bid Immunogen Inc. Up Almost 12% Today,2017-08-30 22:49:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hNDIFkhAGfU/why-investors-bid-immunogen-inc-up-almost-12-today-cm839431,What happened News that Irish biotech Jazz Pharmaceuticals NASDAQ JAZZ had signed on to collaborate with Immunogen Inc NASDAQ IMGN in the development of drugs in the smaller Massachusetts based company s pipeline sent Immunogen shares soaring Tuesday and
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Investors Bid Immunogen Inc. Up Almost 12% Today,2017-08-30 21:39:00 +0000,http://finance.yahoo.com/r/fc7c6d61-0ef5-3362-8313-036a932d2e89/why-investors-bid-immunogen-inc-up-almost-12-today.aspx?yptr=yahoo&.tsrc=rss,Investors continued to warm up to the biotech&apos;s stock after news Tuesday of a licensing deal with Jazz Pharmaceuticals.
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals to Present at the Wells Fargo Securities Healthcare Conference,2017-08-30 20:05:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-present-wells-fargo-200500586.html?.tsrc=rss,"Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update at the conference on Wednesday, September 6, 2017 at 1:15 p.m. EDT / 6:15 p.m. IST.  A live audio webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.  Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.  An archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com."
JAZZ,JAZZ:UW,BBG000G9DVF3,Immunogen Inks Deal With Jazz Pharma to Develop ADC Molecule,2017-08-30 17:50:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fOsa2MUQThA/immunogen-inks-deal-with-jazz-pharma-to-develop-adc-molecule-cm839290,ImmunoGen Inc IMGN announced a strategic collaboration and option agreement 160 160 with Jazz Pharmaceuticals PLC JAZZ for the development and commercialization of two early stage hematology related antibody drug conjugate ADC programs and also another l program which will be
JAZZ,JAZZ:UW,BBG000G9DVF3,Immunogen Inks Deal With Jazz Pharma to Develop ADC Molecule,2017-08-30 15:47:03 +0000,https://finance.yahoo.com/news/immunogen-inks-deal-jazz-pharma-154703311.html?.tsrc=rss,ImmunoGen (IMGN) and Jazz Pharma announced a strategic collaboration to develop and commercialize antibody-drug conjugate products.
JAZZ,JAZZ:UW,BBG000G9DVF3,ImmunoGen (IMGN) in Focus: Stock Moves 17.3% Higher,2017-08-30 14:52:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VDc-bzhLELc/immunogen-imgn-in-focus-stock-moves-173-higher-cm839082,ImmunoGen Inc IMGN was a big mover last session as the company saw its shares rise over 17 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company for the company as the stock is now up 27
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Excellent Value Stocks Based on Low PEG Ratio,2017-08-30 13:53:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6EG45Tkz4vo/5-excellent-value-stocks-based-on-low-peg-ratio-cm838995,The popularity of value investing is on the rise The success of billionaire value investors like Warren Buffett further underscores the fact Per a July Motley Fool article over the past 50 years his conglomerate Berkshire Hathaway s stock has yielded a compound annual return of 20 8
JAZZ,JAZZ:UW,BBG000G9DVF3,ImmunoGen (IMGN) in Focus: Stock Moves 17.3% Higher,2017-08-30 12:56:12 +0000,https://finance.yahoo.com/news/immunogen-imgn-focus-stock-moves-125612789.html?.tsrc=rss,"ImmunoGen (IMGN) was a big mover last session, as the company saw its shares rise over 17% on the day amid huge volumes."
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Excellent Value Stocks Based on Low PEG Ratio,2017-08-30 11:31:11 +0000,https://finance.yahoo.com/news/5-excellent-value-stocks-based-113111967.html?.tsrc=rss,"While P/E alone fails to identify a true value stock, PEG helps find the intrinsic value of a stock."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Why Movado Group, Catalent, and ImmunoGen Jumped Today",2017-08-29 21:50:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FMEjnZOH_BQ/why-movado-group-catalent-and-immunogen-jumped-today-cm838847,The stock market slowly climbed over the course of Tuesday s session as geopolitical events and the continuing aftermath of Hurricane Harvey dominated headlines Investors were initially rattled by growing tensions on the Korean Peninsula following reports that North Korea had fired
JAZZ,JAZZ:UW,BBG000G9DVF3,"Health Care Sector Update for 08/29/2017: IMGN,JAZZ,JUNO,ACOR",2017-08-29 20:28:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vWVybPkW-xQ/health-care-sector-update-for-08292017-imgnjazzjunoacor-cm838824,Top Health Care StocksTop Health Care Stocks JNJ 0 30 JNJ 0 30 PFE 0 01 PFE 0 01 ABT 0 24 ABT 0 24 MRK 0 33 MRK 0 33 AMGN 0 30 AMGN 0 30 Health care stocks have turned narrowly higher again this afternoon with the NYSE Health Care Index adding slightly more than 0 1 in value
JAZZ,JAZZ:UW,BBG000G9DVF3,"Why Movado Group, Catalent, and ImmunoGen Jumped Today",2017-08-29 20:21:05 +0000,http://finance.yahoo.com/r/5e1969b4-fb98-3f77-b8ef-05c688c98bc1/why-movado-group-catalent-and-immunogen-jumped-tod.aspx?yptr=yahoo&.tsrc=rss,"On a positive day for the major benchmarks, these stocks gained. Find out why."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Why ImmunoGen, Inc. Jumped Higher Today",2017-08-29 19:51:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q5-ZBTh9wPA/why-immunogen-inc-jumped-higher-today-cm838801,What happened Shares of ImmunoGen NASDAQ IMGN are up 17 5 at 12 50 p m EDT after the company announced 160 an option deal with Jazz Pharmaceuticals NASDAQ JAZZ for three antibody drug conjugate ADC drugs targeting blood cancers So what The deal covers IMGN779
JAZZ,JAZZ:UW,BBG000G9DVF3,"Why ImmunoGen, Inc. Jumped Higher Today",2017-08-29 17:44:00 +0000,http://finance.yahoo.com/r/c4572abc-a35e-36f8-b5ed-66769ec0ac34/why-immunogen-inc-jumped-higher-today.aspx?yptr=yahoo&.tsrc=rss,A deal with Jazz Pharmaceuticals has investors dancing the Lindy hop.
JAZZ,JAZZ:UW,BBG000G9DVF3,Midday Update: Wall Street Recovers From Overnight Sell-Off as Supports Remain Intact,2017-08-29 17:28:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/frGMni5rxfo/midday-update-wall-street-recovers-from-overnight-sell-off-as-supports-remain-intact-cm838747,With the aid of strong technical support in the Dow and S amp P 500 as well as investor sentiment that the situation in North Korea won t immediately escalate into war the major benchmark averages bounced off their opening lows to trade unchanged to slightly higher at midday on Monday With the
JAZZ,JAZZ:UW,BBG000G9DVF3,ImmunoGen and Jazz Enter Into Global Collaboration,2017-08-29 14:10:44 +0000,https://finance.yahoo.com/news/immunogen-jazz-enter-global-collaboration-141044234.html?.tsrc=rss,"ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs."
JAZZ,JAZZ:UW,BBG000G9DVF3,Acorda Shares Down on FDA's 'Refusal to File' Letter - Biotech Movers,2017-08-29 14:10:00 +0000,http://finance.yahoo.com/r/5d67aa7e-ecd0-32f5-9e3e-b0eaa74fcdaa/acorda-shares-down-on-fda-s-refusal-to-file-letter-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The firm received a ""refusal to file letter"" from the FDA regarding the new drug application for Inbrija, a potential treatment for Parkinson's disease."
JAZZ,JAZZ:UW,BBG000G9DVF3,U.S. Stock Futures Roiled By North Korean Missile Test Over Japan,2017-08-29 13:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fSz-TDT-yIM/us-stock-futures-roiled-by-north-korean-missile-test-over-japan-cm838460,Another provocative missile fired by North Korea roiled global financial markets overnight sending U S stock futures substantially lower ahead of Tuesday s open Losses are widespread throughout most sectors with the notable exception of defense stocks like Lockheed Martin LMT
JAZZ,JAZZ:UW,BBG000G9DVF3,"Health Care Sector Update for 08/29/2017: JNJ, PFE, ABT, MRK, AMGN, IMGN, ETRM",2017-08-29 13:29:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GphX7296_ns/health-care-sector-update-for-08292017-jnj-pfe-abt-mrk-amgn-imgn-etrm-cm838370,Top Health Care Stocks Top Health Care Stocks JNJ 0 9 JNJ 0 9 PFE 1 1 PFE 1 1 ABT 1 ABT 1 MRK 0 5 MRK 0 5 AMGN 0 8 AMGN 0 8 Health care shares were weaker in pre market trade Tuesday Health care shares were weaker in pre market trade Tuesday In sector news
JAZZ,JAZZ:UW,BBG000G9DVF3,See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.,2017-08-29 12:02:44 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120244001.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products",2017-08-29 10:30:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-immunogen-inc-announce-103000343.html?.tsrc=rss,"Jazz Pharmaceuticals plc and ImmunoGen, Inc. today announced that the companies have entered into a collaboration and option agreement granting Jazz Pharmaceuticals exclusive, worldwide rights to opt into development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs, as well as an additional program to be designated during the term of the agreement."
JAZZ,JAZZ:UW,BBG000G9DVF3,Biotech Stocks Facing FDA Decision In September,2017-08-29 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eLoYmPQkXWM/biotech-stocks-facing-fda-decision-in-september-20170829-00502,Biotech Stocks Facing FDA Decision In September
JAZZ,JAZZ:UW,BBG000G9DVF3,Enanta Pharmaceuticals (ENTA) Looks Good: Stock Adds 9.6% in Session,2017-08-28 14:53:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pz1RwC4B-y8/enanta-pharmaceuticals-enta-looks-good-stock-adds-96-in-session-cm837874,Enanta Pharmaceuticals Inc ENTA was a big mover last session as the company saw its shares rise over 9 on the day This breaks the recent trend of the company as the stock is now trading above the volatile price range of 37 91 to 39 80 in the past one month time frame The company
JAZZ,JAZZ:UW,BBG000G9DVF3,Enanta Pharmaceuticals (ENTA) Looks Good: Stock Adds 9.6% in Session,2017-08-28 12:56:12 +0000,https://finance.yahoo.com/news/enanta-pharmaceuticals-enta-looks-good-125612664.html?.tsrc=rss,"Enanta Pharmaceuticals, Inc. (ENTA) was a big mover last session, as the company saw its shares rise over 9% on the day."
JAZZ,JAZZ:UW,BBG000G9DVF3,Analysts Expect 11% Upside For The Holdings of IYH,2017-08-25 14:41:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xRZEXcuCMDU/analysts-expect-11-upside-for-the-holdings-of-iyh-cm837058,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
JAZZ,JAZZ:UW,BBG000G9DVF3,How Jazz Pharmaceuticals Aims to Boost Vyxeos Sales in 2017,2017-08-23 17:06:42 +0000,http://finance.yahoo.com/r/2752f295-6fad-3439-9fd0-17984103ec74/jazz-pharmaceuticals-formulated-multiple-initiatives-support-market-launch-vyxeos-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In early 2017, Jazz Pharmaceuticals (JAZZ) expanded its sales force team from 35 to 55 and expanded its field reimbursement teams to support the commercial launch of Vyxeos in the US."
JAZZ,JAZZ:UW,BBG000G9DVF3,What Jazz Pharmaceuticals Expects for Vyxeos,2017-08-23 15:54:10 +0000,http://finance.yahoo.com/r/aacf76c1-3deb-36e4-9792-cb8b12a1faea/vyxeos-may-prove-robust-therapeutic-option-certain-types-poor-prognosis-aml?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"If Vyxeos manages to penetrate a sizeable portion of the target market, it may have a favorable impact on Jazz Pharmaceuticals stock."
JAZZ,JAZZ:UW,BBG000G9DVF3,JAZZ Is Focused on Increasing Market Adoption of Defitelio,2017-08-23 15:53:47 +0000,http://finance.yahoo.com/r/fae65a20-c116-3f73-9b4a-5d6543e72064/jazz-pharmaceuticals-focused-increasing-market-adoption-defitelio-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Jazz Pharmaceuticals (JAZZ) expects quarterly variability in Defitelio sales as the drug targets hepatic veno-occlusive disease (or VOD), an ultra-rare condition."
JAZZ,JAZZ:UW,BBG000G9DVF3,Understanding Jazz Pharmaceuticals’ Robust Growth Opportunities in 2017,2017-08-23 15:52:54 +0000,http://finance.yahoo.com/r/9e407fe7-c370-3442-bca0-3d12d4085c12/jzp-110-may-prove-robust-growth-opportunity-jazz-pharmaceuticals-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"JAZZ has estimated that ~6.0 million people in the US suffer from obstructive sleep apnea or excessive sleeping, while ~60,000 are affected by narcolepsy."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Is Focused on Label Expansion of Defitelio,2017-08-23 13:53:34 +0000,http://finance.yahoo.com/r/ded68541-58e1-38e6-b89a-701342828e93/jazz-pharmaceuticals-focused-label-expansion-defitelio-2?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Defitelio could help Jazz Pharmaceuticals become a prominent player not only in the treatment but also in the prevention of post-HSCT complications.
JAZZ,JAZZ:UW,BBG000G9DVF3,Defitelio Continues to Demonstrate Robust Demand Trends in 2017,2017-08-23 13:08:01 +0000,http://finance.yahoo.com/r/e4f23521-835a-3e32-8de0-ae539843910c/defitelio-continues-demonstrate-robust-demand-trends-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Jazz Pharmaceuticals expects Defitelio to report revenues in the range of $130 million to $150 million globally in 2017.
JAZZ,JAZZ:UW,BBG000G9DVF3,Inside the Efficacy of JAZZ’s JZP-110 in Obstructive Sleep Apnea Trials,2017-08-23 13:07:00 +0000,http://finance.yahoo.com/r/a5fa8326-6f7a-3fa8-afb4-8d21db76f2f8/jzp-110-demonstrated-efficacy-obstructive-sleep-apnea-tones-3-tones-4-trials?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,This trial demonstrated the efficacy and safety of JAZZ's JZP-110 in both the MWT and sleep latency tests at all dosages at the end of weeks 4 and 12.
JAZZ,JAZZ:UW,BBG000G9DVF3,Erwinaze Sales May Remain Flat in 2017,2017-08-23 11:38:12 +0000,http://finance.yahoo.com/r/578d9f63-9f1e-3434-b504-963eabe8869a/erwinaze-sales-may-remain-flay-year-year-basis-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Erwinaze saw net sales worth $49 million in 2Q17, almost flat compared to the drug’s revenues of $50 million in 2Q16."
JAZZ,JAZZ:UW,BBG000G9DVF3,Inside the Efficacy of JAZZ’s JZP-110 for Excessive Sleepiness,2017-08-23 11:37:06 +0000,http://finance.yahoo.com/r/473a183b-5f8c-399b-9062-733be9059927/jzp-110-demonstrated-efficacy-excessive-sleepiness-indication-tones-2-study?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In its Tones-2 study, JAZZ studied the efficacy and safety of JZP-110 to control excessive sleepiness in narcolepsy patients over a period of 12 weeks."
JAZZ,JAZZ:UW,BBG000G9DVF3,Ironwood Pharma's Combination Gout Drug Gets FDA Approval,2017-08-22 16:41:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kvtlvf1_UFI/ironwood-pharmas-combination-gout-drug-gets-fda-approval-cm835414,Ironwood Pharmaceuticals Inc IRWD announced that the FDA has approved its oral fixed dose combination drug Duzallo for the treatment of hyperuricemia in patients with uncontrolled gout Duzallo is a once daily fixed dose combination of Ironwood s gout drug Zurampic lesinurad and
JAZZ,JAZZ:UW,BBG000G9DVF3,The Future of JAZZ’s Low-Sodium Investigational Drugs,2017-08-22 14:36:43 +0000,http://finance.yahoo.com/r/232885d4-ce48-3a21-9569-9c345080c65b/low-sodium-investigational-drugs-jzp-507-jzp-508-may-reduce-xyrems-revenues-future-years?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"A 9-mg dose of JAZZ's Xyrem, which contains 1,640 mg of sodium, has caused physicians to be reluctant to prescribe the drug to ~20% of their patients."
JAZZ,JAZZ:UW,BBG000G9DVF3,Rally Set to Resume: Buy These 5 Value Picks on the Dip,2017-08-22 13:41:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zj2CIUOz3nc/rally-set-to-resume-buy-these-5-value-picks-on-the-dip-cm835259,These are tough times for U S markets for sure Investors are smarting from two straight weeks of losses and the Trump administration s recent actions have only added to their worries From frequent departures at Trump s core team to heightened tensions with North Korea surely markets have
JAZZ,JAZZ:UW,BBG000G9DVF3,This Alone Could Boost Xyrem’s Addressable Market in 2018,2017-08-22 13:07:11 +0000,http://finance.yahoo.com/r/0bc35aa8-9bc1-333d-9ad0-97e0ce5e29e8/label-revision-may-boost-xyrems-addressable-market-size-2018?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"To expand Xyrem’s addressable market, JAZZ has been evaluating the efficacy of Xyrem in pediatric narcolepsy patients with cataplexy and excessive sleepiness."
JAZZ,JAZZ:UW,BBG000G9DVF3,Rally Set to Resume: Buy These 5 Value Picks on the Dip,2017-08-22 12:26:12 +0000,https://finance.yahoo.com/news/rally-set-resume-buy-5-122612977.html?.tsrc=rss,Morgan Stanley believes that conditions for a Bull Run remain in place.
JAZZ,JAZZ:UW,BBG000G9DVF3,See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.,2017-08-22 12:05:03 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120503423.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
JAZZ,JAZZ:UW,BBG000G9DVF3,Behind Xyrem’s Solid Demand Trends in 2017,2017-08-22 11:37:28 +0000,http://finance.yahoo.com/r/e06b2d3f-a30b-3c29-aa30-e6e7a37a369a/xyrem-continues-witness-solid-demand-trends-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Jazz Pharmaceuticals’ (JAZZ) Xyrem reported revenues of ~$298 million, which represented a YoY (year-over-year) growth of ~6% and sequential growth of ~9%."
JAZZ,JAZZ:UW,BBG000G9DVF3,Inside Jazz’s Net Profit Margin Expectations for 2017,2017-08-21 20:05:52 +0000,http://finance.yahoo.com/r/b72f5641-6005-32fc-9a2b-52d5234d08f2/jazz-pharmaceuticals-expected-report-slight-drop-net-profit-margins-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"For 2Q17, Jazz Pharmaceuticals (JAZZ) reported revenues close to $394 million, which represented a YoY growth of ~3% and sequential growth ~5%."
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Jazz Is Expected to Report a Robust Revenue Growth Rate,2017-08-21 18:36:12 +0000,http://finance.yahoo.com/r/36aa9846-9e24-31be-b73b-b1819c02e276/jazz-pharmaceuticals-expected-report-robust-revenue-growth-rate-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On August 3, JAZZ managed to secure regulatory approval from the FDA for its innovative drug, Vyxeos, as a treatment option for two types of acute myeloid leukemia."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz on the Street: Analysts’ Recommendations for JAZZ in August,2017-08-21 17:02:04 +0000,http://finance.yahoo.com/r/e86ec639-2c61-3dac-a906-9c73e1a55491/analysts-recommendations-jazz-pharmaceuticals-peers-august-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,JAZZ is now engaged in patent litigations involving Xyrem in the US with four other generic players.
JAZZ,JAZZ:UW,BBG000G9DVF3,Featured Company News - Jazz Pharma Offers Exchangeable Senior Notes Due 2024,2017-08-21 11:00:00 +0000,https://finance.yahoo.com/news/featured-company-news-jazz-pharma-110000536.html?.tsrc=rss,"Research Desk Line-up: Kite Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 21, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Jazz ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Arm Announces $500M Senior Notes Offer,2017-08-18 16:40:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0PQunh2l3n4/jazz-pharmaceuticals-arm-announces-500m-senior-notes-offer-cm833989,Jazz Pharmaceuticals Public Limited Company JAZZ announced that its wholly owned subsidiary Jazz Investments I Limited intends to offer exchangeable Senior Notes due 2024 for an aggregate principal amount of 500 million in a private offering to qualified institutional buyers Notably
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Securities Limited -- Moody's raises Jazz's sr. secured to Ba1 from Ba2; affirms Ba3 CFR,2017-08-18 15:13:07 +0000,http://finance.yahoo.com/r/77c83558-c160-3038-962b-5369480187c4/viewresearchdoc.aspx?docid=PR_371466&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170818_PR_371466&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's raises Jazz's sr. secured to Ba1 from Ba2; affirms Ba3 CFR. Global Credit Research- 18 Aug 2017. New York, August 18, 2017-- Moody's Investors Service upgraded the senior secured ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Arm Announces $500M Senior Notes Offer,2017-08-18 14:28:02 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-arm-announces-500m-142802537.html?.tsrc=rss,Jazz Pharmaceuticals (JAZZ) announces private offering of exchangeable senior notes to qualified institutional buyers to raise proceeds and repay debt.
JAZZ,JAZZ:UW,BBG000G9DVF3,Biotech Movers: Jazz Shares Lower Amid Notes Offering,2017-08-18 13:56:00 +0000,http://finance.yahoo.com/r/686680d6-6751-3451-8012-0347ff22ae91/biotech-movers-jazz-shares-lower-amid-notes-offering.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The Dublin firm announced an offering of $500 million of exchangeable senior notes due 2024.
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Offering of $500 Million of 1.50% Exchangeable Senior Notes due 2024,2017-08-18 11:00:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-offering-500-110000698.html?.tsrc=rss,"DUBLIN, Aug. 18, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) (""Jazz Pharmaceuticals"") today announced an offering by Jazz Investments I Limited, its wholly-owned subsidiary (the ""Issuer""), of $500 million aggregate principal amount of 1.50% exchangeable senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the ""Securities Act"").  The Issuer has also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $75 million aggregate principal amount of notes.  The sale of the notes is expected to close on August 23, 2017, subject to customary closing conditions.  Jazz Pharmaceuticals intends to use the net proceeds from this offering to repay all or a substantial portion of $500 million of outstanding borrowings under its revolving credit facility.  Any remaining net proceeds will be used for general corporate purposes, including potential business development activities."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Offering of $500 Million of Exchangeable Senior Notes due 2024,2017-08-17 20:07:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-offering-500-200700721.html?.tsrc=rss,"DUBLIN, Aug. 17, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced an offering by Jazz Investments I Limited, its wholly-owned subsidiary (the ""Issuer""), of $500 million aggregate principal amount of exchangeable senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the ""Securities Act"").  The Issuer has also granted the initial purchasers a 13-day option to purchase up to an additional $75 million aggregate principal amount of notes.  Jazz Pharmaceuticals plc intends to use the net proceeds from this offering to repay all or a substantial portion of $500 million of outstanding borrowings under its revolving credit facility.  Any remaining net proceeds will be used for general corporate purposes, including potential business development activities."
JAZZ,JAZZ:UW,BBG000G9DVF3,Endo International (ENDP) Jumps: Stock Rises 6.9%,2017-08-17 14:42:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dCMdeny1vWw/endo-international-endp-jumps-stock-rises-69-cm833238,Endo International plc ENDP was a big mover last session as the company saw its shares rise almost 7 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 14 6 in
JAZZ,JAZZ:UW,BBG000G9DVF3,Jounce Therapeutics (JNCE) Jumps: Stock Moves 7.4% Higher,2017-08-17 13:41:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HFBqU6FlDac/jounce-therapeutics-jnce-jumps-stock-moves-74-higher-cm833260,Jounce Therapeutics Inc JNCE was a big mover last session as its shares rose over 7 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above the volatile
JAZZ,JAZZ:UW,BBG000G9DVF3,Edited Transcript of JAZZ earnings conference call or presentation 8-Aug-17 8:30pm GMT,2017-08-15 12:25:54 +0000,https://finance.yahoo.com/news/edited-transcript-jazz-earnings-conference-025837544.html?.tsrc=rss,Q2 2017 Jazz Pharmaceuticals PLC Earnings Call
JAZZ,JAZZ:UW,BBG000G9DVF3,Earnings Review and Free Research Report: Illumina Reported Better Than Expected Revenue and Earnings Results,2017-08-15 11:00:00 +0000,https://finance.yahoo.com/news/earnings-review-free-research-report-110000932.html?.tsrc=rss,"Research Desk Line-up: Jazz Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 15, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Illumina, Inc. (NASDAQ: ILMN ), ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.,2017-08-12 12:06:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120637753.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
JAZZ,JAZZ:UW,BBG000G9DVF3,"RK Capital Management, LLC Buys Electronics for Imaging Inc, Douglas Dynamics Inc, KBR Inc, ...",2017-08-12 10:34:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8XrhHdpT0QU/rk-capital-management-llc-buys-electronics-for-imaging-inc-douglas-dynamics-inc-kbr-inc-cm831271,RK Capital Management LLC New Purchases EFII PLOW KBR SNHY GMS TLGT Added Positions DCI TACO IBP EMKR ODFL DLX JRVR QTNA AIMC MANT Reduced Positions EXTR CCOI ROLL PATK JAZZ FORM JILL PENN LFUS CVTI Sold Out MMS LCII DY
JAZZ,JAZZ:UW,BBG000G9DVF3,The 3 Top Stocks for Your IRA in August,2017-08-10 14:37:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rPf05Zi2aj0/the-3-top-stocks-for-your-ira-in-august-cm830110,August is the best month for you to add to your individual retirement account IRA since July The truth is that regularly adding to your retirement accounts is a really smart way to achieve your long term goals Markets will go up and they ll go down but time is on your side
JAZZ,JAZZ:UW,BBG000G9DVF3,The 3 Top Stocks for Your IRA in August,2017-08-10 13:03:00 +0000,http://finance.yahoo.com/r/6a843c9c-cfbc-3f3e-ae2c-a1abb7091884/the-3-top-stocks-for-your-ira-in-august.aspx?yptr=yahoo&.tsrc=rss,"Why IBM, Facebook, and Jazz Pharmaceuticals look like smart picks for your IRA."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharma (JAZZ) Q2 Earnings & Revenues Miss, View Intact",2017-08-09 20:36:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/19p9nfmf3Pk/jazz-pharma-jazz-q2-earnings-revenues-miss-view-intact-cm829785,Jazz Pharmaceuticals Public Limited Company JAZZ reported second quarter 2017 earnings of 1 72 per share which missed the Zacks Consensus Estimate of 1 85 Adjusted earnings of 2 12 per share including stock based compensation expenses decreased 6 2 from the year ago figure Jazz
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharma (JAZZ) Q2 Earnings & Revenues Miss, View Intact",2017-08-09 18:15:06 +0000,https://finance.yahoo.com/news/jazz-pharma-jazz-q2-earnings-181506937.html?.tsrc=rss,"Jazz Pharma&apos;s (JAZZ) earnings and revenues miss estimates. However, the top line rises year over year owing to higher sales of the company&apos;s marketed drug, Xyrem."
JAZZ,JAZZ:UW,BBG000G9DVF3,Stocks Pare Losses; Why Is Boeing Down When Defense Firms Are Up?,2017-08-09 17:42:17 +0000,http://finance.yahoo.com/r/28c08793-f120-3db1-9094-c4b73455092b/stocks-pare-losses-why-is-boeing-down-when-defense-stocks-are-up?src=A00220&yptr=yahoo&.tsrc=rss,"Stocks pared losses in afternoon trading Wednesday, as the threat of an attack from North Korea and earnings reports influenced some movement in the market."
JAZZ,JAZZ:UW,BBG000G9DVF3,Oversold Conditions For Jazz Pharmaceuticals (JAZZ),2017-08-09 17:36:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7mNlv4O0Png/oversold-conditions-for-jazz-pharmaceuticals-jazz-cm829595,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz misses Street 2Q forecasts,2017-08-09 03:05:48 +0000,https://finance.yahoo.com/news/jazz-misses-street-2q-forecasts-220457110.html?.tsrc=rss,"On a per-share basis, the Dublin-based company said it had net income of $1.72. Earnings, adjusted for non-recurring costs and stock option expense, were $2.56 per share. The results did not meet Wall ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz misses Street 2Q forecasts,2017-08-08 22:04:57 +0000,https://finance.yahoo.com/news/jazz-misses-street-2q-forecasts-220457036.html?.tsrc=rss,"On a per-share basis, the Dublin-based company said it had net income of $1.72. Earnings, adjusted for non-recurring costs and stock option expense, were $2.56 per share. The results did not meet Wall ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals shares fall after results miss Street estimates,2017-08-08 21:19:26 +0000,http://finance.yahoo.com/r/e8bcce1c-149a-31da-aa1d-7341e670c759/Story.aspx?guid=7E6AFCD9-1BDB-4A13-92BA-68E6D4A1FEC7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Jazz Pharmaceuticals PLC shares dropped in the extended session Tuesday after the biotech company fell short of Wall Street estimates for quarterly results and affirmed its outlook for the year. Jazz shares ...
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Second Quarter 2017 Financial Results,2017-08-08 20:05:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-second-quarter-200500867.html?.tsrc=rss,"DUBLIN , Aug. 8, 2017 /PRNewswire/ --  Received FDA Approval of Vyxeos for the Treatment of Adults with Newly-Diagnosed Therapy-Related Acute Myeloid Leukemia (t-AML) or AML with Myelodysplasia-Related ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"After-Hours Earnings Report for August 8, 2017 :  DIS, PCLN, MNST, ETP, ETE, FNV, CLR, ANDV, IFF, JAZZ, XEC, CLNS",2017-08-08 18:27:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3IVZFOXcb2g/after-hours-earnings-report-for-august-8-2017-dis-pcln-mnst-etp-ete-fnv-clr-andv-iff-jazz-xec-clns-cm828955,The following companies are expected to report earnings after hours on 08 08 2017 Visit our Earnings Calendar for a full list of expected earnings releases Walt Disney Company DIS is reporting for the quarter ending June 30 2017 The media company
JAZZ,JAZZ:UW,BBG000G9DVF3,Investor Network: Jazz Pharmaceuticals Plc to Host Earnings Call,2017-08-08 15:00:00 +0000,https://finance.yahoo.com/news/investor-network-jazz-pharmaceuticals-plc-150000709.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Jazz Pharmaceuticals Plc (NASDAQ: JAZZ ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, 2017 at 4:30 PM ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More",2017-08-07 14:32:02 +0000,https://finance.yahoo.com/news/drug-stocks-q2-earnings-roster-143202883.html?.tsrc=rss,A look at the pharma/biotech companies that are set to report second-quarter results on Aug 8.
JAZZ,JAZZ:UW,BBG000G9DVF3,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar",2017-08-04 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5id7u3diVtI/dvax-plunges-on-delay-in-approval-fda-nod-for-abbvs-hcv-drug-abio-on-radar-20170804-00064,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar"
JAZZ,JAZZ:UW,BBG000G9DVF3,Can Jazz Pharma (JAZZ) Spring a Surprise in Q2 Earnings?,2017-08-03 22:59:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K5z3a--Zfgs/can-jazz-pharma-jazz-spring-a-surprise-in-q2-earnings-cm826910,Jazz Pharmaceuticals plc JAZZ is scheduled to report second quarter 2017 results on Aug 8 after the market closes Jazz s shares have significantly outperformed the industry so far this year The stock has surged 37 9 compared with the industry s 1 7 increase during the
JAZZ,JAZZ:UW,BBG000G9DVF3,Can Jazz Pharma (JAZZ) Spring a Surprise in Q2 Earnings?,2017-08-03 21:10:09 +0000,https://finance.yahoo.com/news/jazz-pharma-jazz-spring-surprise-211009863.html?.tsrc=rss,"Jazz Pharma&apos;s (JAZZ) lead drug, Xyrem, is likely to deliver a strong performance in Q2, thanks to label expansion efforts."
JAZZ,JAZZ:UW,BBG000G9DVF3,FDA Oks Treatment For Certain Types Of Poor-prognosis Acute Myeloid Leukemia,2017-08-03 21:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_8dBYL24ZAA/fda-oks-treatment-for-certain-types-of-poorprognosis-acute-myeloid-leukemia-20170803-02377,FDA Oks Treatment For Certain Types Of Poor-prognosis Acute Myeloid Leukemia
JAZZ,JAZZ:UW,BBG000G9DVF3,Drug developer jazzed to receive FDA approval for leukemia treatment,2017-08-03 17:00:13 +0000,http://finance.yahoo.com/r/c1531e9b-d402-38d0-9aca-0de186f6c4b1/jazz-pharmaceuticals-fda-approval-vyxeos-leukemia.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Jazz Pharmaceuticals, a drug developer based in Ireland that is in the process of expanding its U.S. presence in Philadelphia, received Food and Drug Administration approval Thursday for its experimental leukemia treatment.  The FDA approved Vyxeos as an injectable therapy for adults with two types of acute myeloid leukemia, a rapidly progressing and life-threatening blood cancer.  Bruce Cozadd, chairman and CEO of Jazz Pharmaceuticals (JAZZ), said Vyxeos is the first new chemotherapy advance in more than 40 years for adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Webcast for Vyxeos Investor Update,2017-08-03 14:15:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-webcast-vyxeos-141500636.html?.tsrc=rss,"DUBLIN, Aug. 3, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the company will host a webcast on Monday, August 7, 2017 at 4:30 p.m. EDT/9:30 p.m. IST to provide investors with an update on Vyxeos™ (daunorubicin and cytarabine) liposome for injection, which was approved by the U.S. Food and Drug Administration on August 3, 2017 for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).  The webcast will include an overview of AML from invited physician experts as well as a Vyxeos overview from the company's senior management.  Interested parties may access the webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.  Please connect to the website prior to the start of the webcast to ensure adequate time for any software downloads that may be necessary to listen to the webcast."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces FDA Approval of Vyxeos™ (daunorubicin and cytarabine) Liposome for Injection for the Treatment of Adults with Newly-Diagnosed Therapy-Related Acute Myeloid Leukemia (t-AML) or AML with Myelodysplasia-Related Changes (AML-MRC),2017-08-03 14:10:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-fda-approval-141000967.html?.tsrc=rss,"DUBLIN, Aug. 3, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has approved Vyxeos™ (daunorubicin and cytarabine) liposome for injection for the treatment of adults with two types of Acute Myeloid Leukemia (AML), a rapidly progressing and life-threatening blood cancer.  Vyxeos is indicated for the treatment of adults with newly-diagnosed t-AML or AML-MRC."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : August 1, 2017",2017-08-01 13:24:46 +0000,http://finance.yahoo.com/r/2b90535a-9363-3682-bcfe-8044ca869bd7/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bearish-manner-jazz-us-august-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation® Technology to Develop Long-Acting Asparaginase Product Candidates,2017-07-26 20:05:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-xl-protein-gmbh-200500491.html?.tsrc=rss,"DUBLIN, July 26, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that it has entered into a license agreement with XL-protein GmbH (""XLp"") for the rights to develop, manufacture and commercialize products using XLp's PASylation® Technology to extend the plasma half-life of selected asparaginase product candidates.  Under the terms of the agreement, Jazz will gain access to XLp's PASylation technology to enable construction of asparaginase molecules intended to extend both the circulating half-life and the duration of therapeutic effect.  Jazz has paid an upfront payment of $2 million and will pay XLp for services and support as specified in the license agreement and for the achievement of certain development, regulatory and commercial milestone events, as well as royalties.  Other financial terms are not disclosed."
JAZZ,JAZZ:UW,BBG000G9DVF3,Sum Up The Pieces: PPH Could Be Worth $65,2017-07-25 13:59:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VuUDSjXu_DA/sum-up-the-pieces-pph-could-be-worth-65-cm820667,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETFs with exposure to Jazz Pharmaceuticals Plc : July 24, 2017",2017-07-24 20:47:52 +0000,http://finance.yahoo.com/r/9e3600ac-016b-3432-ad09-f991577669c1/etfs-with-exposure-to-jazz-pharmaceuticals-plc-july-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Jazz Pharmaceuticals Plc Here are 5 ETFs with the largest exposure to JAZZ-US. Comparing the performance and risk of Jazz Pharmaceuticals Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals to Report 2017 Second Quarter Financial Results on August 8, 2017",2017-07-24 20:05:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-report-2017-second-200500677.html?.tsrc=rss,"DUBLIN , July 24, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2017 second quarter financial results on Tuesday, August 8, 2017 , after the close ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETFs with exposure to Jazz Pharmaceuticals Plc : July 14, 2017",2017-07-14 19:08:54 +0000,http://finance.yahoo.com/r/04db514e-2948-3821-aea5-a8ba066ea6a9/etfs-with-exposure-to-jazz-pharmaceuticals-plc-july-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Jazz Pharmaceuticals Plc Here are 5 ETFs with the largest exposure to JAZZ-US. Comparing the performance and risk of Jazz Pharmaceuticals Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,Top 5 Biotech Stocks for 2017,2017-07-12 20:17:00 +0000,http://finance.yahoo.com/r/a70d790c-f5ba-3ad9-a649-8a90d9a4bb34/biotech-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Biotech can be risky, but these top biotech stocks have stable track records."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc – Value Analysis (NASDAQ:JAZZ) : July 12, 2017",2017-07-12 19:25:58 +0000,http://finance.yahoo.com/r/936b7f77-9c9c-3ebe-8a51-28206643f11a/jazz-pharmaceuticals-plc-value-analysis-nasdaqjazz-july-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Jazz Pharmaceuticals Plc a score of 91. Our analysis is based on comparing Jazz Pharmaceuticals Plc with the following peers – Endo International Plc, Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries Limited Sponsored ADR, Paratek Pharmaceuticals Inc, AmerisourceBergen Corporation and Novartis AG Sponsored ADR (ENDP-US, VRX-US, TEVA-US, ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : July 11, 2017",2017-07-11 13:20:54 +0000,http://finance.yahoo.com/r/29d0d408-5004-32da-8352-37bee4e75e72/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bearish-manner-jazz-us-july-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,This Rebounding Pharma Stock May Launch Another Breakout Move,2017-06-30 20:14:53 +0000,http://finance.yahoo.com/r/2bc05d5c-de3c-3061-8fe5-9a918d7fbba7/this-rebounding-pharma-stock-may-launch-another-breakout-move?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Jazz Pharmaceuticals shows improving technical performance.
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Is Barclays Optimistic about Jazz Pharmaceuticals?,2017-06-30 13:06:56 +0000,http://finance.yahoo.com/r/0b05ebbc-bf92-35c0-b636-cc04fe58ba85/barclays-optimistic-jazz-pharmaceuticals?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"According to Barclays, Jazz Pharmaceuticals focuses on new product developments that will drive its growth."
JAZZ,JAZZ:UW,BBG000G9DVF3,AVEO's Kidney Cancer Candidate Gets CHMP Recommendation,2017-06-27 14:54:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YreC2kI--0M/aveos-kidney-cancer-candidate-gets-chmp-recommendation-cm808839,AVEO Pharmaceuticals Inc AVEO announced on Friday that the Committee for Medicinal Products for Human Use CHMP has recommended the approval of its lead candidate Fotivda tivozanib for the treatment of advanced renal cell carcinoma RCC We note that the European Commission
JAZZ,JAZZ:UW,BBG000G9DVF3,Edited Transcript of JAZZ earnings conference call or presentation 9-May-17 8:30pm GMT,2017-06-26 14:36:13 +0000,https://finance.yahoo.com/news/edited-transcript-jazz-earnings-conference-030735425.html?.tsrc=rss,Q1 2017 Jazz Pharmaceuticals PLC Earnings Call
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : June 22, 2017",2017-06-22 12:14:41 +0000,http://finance.yahoo.com/r/f81a4139-6a4c-3963-a72b-0eaf6b400bb5/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bullish-manner-jazz-us-june-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Reasons Jazz Pharmaceuticals Stock Could Fall,2017-06-18 12:19:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vbg9FrO64TA/3-reasons-jazz-pharmaceuticals-stock-could-fall-cm804774,The good times are rolling these days for Jazz Pharmaceuticals NASDAQ JAZZ Jazz stock is up more than 35 so far in 2017 thanks in part to great results from late stage studies of sleep disorder drug JZP 110 But what goes up can always come down Several risks remain for
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Reasons Jazz Pharmaceuticals Stock Could Fall,2017-06-18 11:07:00 +0000,http://finance.yahoo.com/r/15ff3517-6ef2-3da4-bd66-2d30384d8b08/3-reasons-jazz-pharmaceuticals-stock-could-fall.aspx?yptr=yahoo&.tsrc=rss,Jazz Pharmaceuticals stock has soared in 2017. Could gravity be about to take its toll?
JAZZ,JAZZ:UW,BBG000G9DVF3,"IHE, ZTS, MYL, JAZZ: Large Outflows Detected at ETF",2017-06-16 16:09:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lR37POQk_Ws/ihe-zts-myl-jazz-large-outflows-detected-at-etf-cm804403,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Pharmaceuticals ETF Symbol IHE where we have detected an approximate 22 6 million dollar outflow that s a 3 2 decrease week over week
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Mid-Cap Stocks With Big-Cap Potential,2017-06-15 17:08:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NmffVq2o-sY/3-mid-cap-stocks-with-big-cap-potential-cm803932,Want to see your money grow as quickly as possible Recent history suggests that mid cap stocks or those typically defined as having market caps of between 2 billion and 10 billion are what you should consider buying According to Morningstar a hypothetical 10 000 invested on
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Mid-Cap Stocks With Big-Cap Potential,2017-06-15 15:44:00 +0000,http://finance.yahoo.com/r/008caaef-5c0a-32a8-81c6-04bc181e3a32/3-mid-cap-stocks-with-big-cap-potential.aspx?yptr=yahoo&.tsrc=rss,Just add water and watch these stocks grow.
JAZZ,JAZZ:UW,BBG000G9DVF3,Top 5 Biotech Stocks for 2017,2017-06-14 15:49:00 +0000,http://finance.yahoo.com/r/efb525c8-14a6-3cc1-b339-fd362a986535/biotech-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Biotech can be risky, but these top biotech stocks have stable track records."
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Is Jazz Pharmaceuticals (JAZZ) Down 3.3% Since the Last Earnings Report?,2017-06-13 10:27:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1BbocebI-Ns/why-is-jazz-pharmaceuticals-jazz-down-33-since-the-last-earnings-report-cm802433,A month has gone by since the last earnings report for Jazz Pharmaceuticals PLC JAZZ Shares have lost about 3 3 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Is Jazz Pharmaceuticals (JAZZ) Down 3.3% Since the Last Earnings Report?,2017-06-13 08:25:08 +0000,https://finance.yahoo.com/news/why-jazz-pharmaceuticals-jazz-down-082508369.html?.tsrc=rss,Jazz Pharmaceuticals (JAZZ) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Value Stocks for Skillful Investors,2017-06-10 14:27:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T1NxkTC-CAU/3-value-stocks-for-skillful-investors-cm801588,Value investors aim to buy stocks trading at a discount to their intrinsic net worth That s an easy enough concept to grasp but putting it to work in the real world takes a great deal of skill With that in mind we asked a team of Fools to identify a company that they believe
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Value Stocks for Skillful Investors,2017-06-10 13:09:00 +0000,http://finance.yahoo.com/r/0e1a7e56-329f-37af-9d1d-f7015725807c/3-value-stocks-for-skillful-investors.aspx?yptr=yahoo&.tsrc=rss,"Are you searching for value in today&apos;s market? Here&apos;s why you should consider Jazz Pharmaceuticals, IBM, and General Motors."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : June 9, 2017",2017-06-09 12:37:29 +0000,http://finance.yahoo.com/r/a5f340a2-4ecc-31ae-8ccb-3b08a31040dc/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bullish-manner-jazz-us-june-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Sleep Disorder Candidate Positive in Phase III,2017-06-07 17:28:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t_h_xfQu2rU/jazz-pharma-sleep-disorder-candidate-positive-in-phase-iii-cm800157,Jazz Pharmaceuticals plc JAZZ announced positive efficacy results from studies evaluating its lead pipeline candidate JZP 110 in adult patients with excessive sleepiness ES associated with narcolepsy and obstructive sleep apnea OSA The data were presented at the 31st
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Sleep Disorder Candidate Positive in Phase III,2017-06-07 14:52:02 +0000,https://finance.yahoo.com/news/jazz-pharma-sleep-disorder-candidate-145202322.html?.tsrc=rss,"Jazz Pharmaceuticals plc (JAZZ) announced positive efficacy results from studies evaluating its lead pipeline candidate, JZP-110, in adult patients with excessive sleepiness (ES) associated with narcolepsy and obstructive sleep apnea (OSA)."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Presents JZP-110 Data in Patients with Excessive Sleepiness Associated with Obstructive Sleep Apnea,2017-06-06 21:05:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-presents-jzp-110-210500447.html?.tsrc=rss,"DUBLIN, June 6, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented positive efficacy results from its global multicenter studies (TONES 3 and TONES 4) of JZP-110 in adult patients ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Presents Data for the Phase 3 TONES 2 Study of JZP-110 in Patients with Excessive Sleepiness Associated with Narcolepsy,2017-06-06 21:00:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-presents-data-phase-210000276.html?.tsrc=rss,"DUBLIN, June 6, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today presented the positive efficacy results from its global multicenter study of JZP-110 in adult patients with excessive sleepiness associated with narcolepsy.  The data were presented today in a poster session at the 31st Associated Professional Sleep Societies (APSS) Annual SLEEP Meeting in Boston."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals' Vyxeos NDA Granted Priority Review,2017-06-01 17:32:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WUUSCLE-ocs/jazz-pharmaceuticals-vyxeos-nda-granted-priority-review-cm797548,Jazz Pharmaceuticals plc JAZZ announced that the New Drug Application NDA for its experimental leukemia candidate Vyxeos has been accepted for priority review by the FDA The specialty biopharmaceutical company is looking to get Vyxeos cytarabine and daunorubicin liposome injection
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals&apos; Vyxeos NDA Granted Priority Review,2017-06-01 15:19:03 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-apos-vyxeos-nda-151903810.html?.tsrc=rss,Jazz Pharmaceuticals plc (JAZZ) announced that the New Drug Application (NDA) for its experimental leukemia candidate Vyxeos has been accepted for priority review by the FDA.
JAZZ,JAZZ:UW,BBG000G9DVF3,"FDA Greenlights Novo Nordisk's Rebinyn, TEVA's HALO Shines, LUCY Walks The Talk",2017-06-01 02:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZSL3n-VW7QM/fda-greenlights-novo-nordisks-rebinyn-tevas-halo-shines-lucy-walks-the-talk-20170601-00063,"FDA Greenlights Novo Nordisk's Rebinyn, TEVA's HALO Shines, LUCY Walks The Talk"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Announces FDA Acceptance of NDA for VYXEOS™ (CPX-351), an Investigational Treatment for Acute Myeloid Leukemia, with Priority Review Status",2017-05-31 20:05:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-fda-acceptance-200500460.html?.tsrc=rss,Priority Review status is designated for drugs that may offer major advances in treatment or provide a treatment where no adequate therapy exists.  The granting of Priority Review for the VYXEOS NDA accelerates the timing of the FDA review of the application compared to a standard review.
JAZZ,JAZZ:UW,BBG000G9DVF3,Blog Coverage: Endocyte to Present Posters on its Lead Clinical Stage Assets at the ASCO Annual Meeting,2017-05-31 12:15:00 +0000,https://finance.yahoo.com/news/blog-coverage-endocyte-present-posters-121500048.html?.tsrc=rss,"Upcoming AWS Coverage on Jazz Pharma Post-Earnings Results LONDON, UK / ACCESSWIRE / May 31, 2017 / Active Wall St. blog coverage looks at the headline from Endocyte, Inc. (NASDAQ: ECYT ) as the Company, ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : May 29, 2017",2017-05-29 12:22:58 +0000,http://finance.yahoo.com/r/60a08b26-3ea6-3a3e-88b9-bfe08877a45a/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bearish-manner-jazz-us-may-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS,2017-05-24 20:07:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-webcast-discussion-200700657.html?.tsrc=rss,"DUBLIN, May 24, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the company will host a webcast to discuss data to be presented on JZP-110 and Xyrem® (sodium oxybate) oral solution during the Associated Professional Sleep Societies (APSS) Annual Meeting taking place from June 3-7, 2017 in Boston, MA.  The live webcast will begin at 7:00 p.m. EDT on June 6, 2017.  The webcast may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals to Present Phase 3 Data on JZP-110, an Investigational Treatment for Excessive Sleepiness in Patients with Narcolepsy and with Obstructive Sleep Apnea, During 31st Annual SLEEP Meeting",2017-05-24 20:05:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-present-phase-3-200500159.html?.tsrc=rss,"DUBLIN, Ireland, May 24, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that twelve abstracts supporting the company's sleep medicine portfolio, including data on its investigational ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,BioLineRx Makes Regulatory Submission for Trial of BL-8040,2017-05-23 23:11:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5suWswieSTA/biolinerx-makes-regulatory-submission-for-trial-of-bl-8040-cm793603,BioLineRx Ltd BLRX announced that it has submitted a regulatory filing required to start a phase Ib study for BL 8040 in combination with Roche Group s RHHBY Tecentriq atezolizumab We note that Tecentriq is an anti PDL1 cancer immunotherapy for the maintenance treatment of patients
JAZZ,JAZZ:UW,BBG000G9DVF3,BioLineRx Makes Regulatory Submission for Trial of BL-8040,2017-05-23 21:23:09 +0000,https://finance.yahoo.com/news/biolinerx-makes-regulatory-submission-trial-212309056.html?.tsrc=rss,BioLineRx Ltd. (BLRX) announced that it has submitted a regulatory filing required to start a phase Ib study for BL-8040 in combination with Roche Group&apos;s (RHHBY) Tecentriq (atezolizumab).
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETFs with exposure to Jazz Pharmaceuticals Plc : May 22, 2017",2017-05-22 17:48:38 +0000,http://finance.yahoo.com/r/347d819a-c4fd-3597-af32-13e875ddc57c/etfs-with-exposure-to-jazz-pharmaceuticals-plc-may-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Jazz Pharmaceuticals Plc Here are 5 ETFs with the largest exposure to JAZZ-US. Comparing the performance and risk of Jazz Pharmaceuticals Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Value Stocks for Ambitious Investors,2017-05-21 15:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VlKm6WhirZI/3-value-stocks-for-ambitious-investors-cm792343,Deep value stocks aren t for the faint of heart That said ambitious investors can find incredible profit opportunities among stocks that are so beaten down that the current price the stock market assigns to the whole company isn t much more than its core assets are worth After all
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Value Stocks for Ambitious Investors,2017-05-21 13:04:00 +0000,http://finance.yahoo.com/r/27235e5c-4e9e-362a-8505-e35d37282a5c/3-value-stocks-for-ambitious-investors.aspx?yptr=yahoo&.tsrc=rss,Feeling brave? These value stocks could provide incredible returns to investors willing to take on the risk.
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017",2017-05-19 14:00:50 +0000,http://finance.yahoo.com/r/aebf1140-fa66-3355-ab56-ef84a76785fa/jazz-pharmaceuticals-plc-jazz-us-earnings-analysis-q1-2017-by-the-numbers-may-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Jazz Pharmaceuticals Plc reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Jazz Pharmaceuticals Plc – Endo International Plc, Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries Limited Sponsored ADR, Paratek Pharmaceuticals Inc, AmerisourceBergen Corporation and Novartis AG Sponsored ADR (ENDP-US, ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : May 18, 2017",2017-05-18 12:40:16 +0000,http://finance.yahoo.com/r/a28deb4d-849e-362f-9ead-742409ade61e/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bearish-manner-jazz-us-may-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
JAZZ,JAZZ:UW,BBG000G9DVF3,The Implied Analyst 12-Month Target For PPH,2017-05-17 14:13:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cYEKScf1HTc/the-implied-analyst-12-month-target-for-pph-cm790455,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences,2017-05-16 20:05:00 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-announces-participation-two-200500795.html?.tsrc=rss,"UBS Global Healthcare Conference in New York, NY on Tuesday, May 23, 2017 at 1:00 p.m. EDT / 6:00 p.m. IST.  Russell Cox, executive vice president and chief operating officer, will provide an overview of the company and a business and financial update.  A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.  Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast."
JAZZ,JAZZ:UW,BBG000G9DVF3,4 of the Cheapest Biotech Stocks in the World,2017-05-11 16:06:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x2RV_FePCyg/4-of-the-cheapest-biotech-stocks-in-the-world-cm788001,When you think of biotech stocks cheap is probably the last word that comes to mind Most biotech stocks aren t profitable and many have no products currently on pharmacy shelves This means biotech valuations tend to be a hodgepodge of investor emotions future peak
JAZZ,JAZZ:UW,BBG000G9DVF3,4 of the Cheapest Biotech Stocks in the World,2017-05-11 04:00:00 +0000,http://finance.yahoo.com/r/c2084956-a67d-3e34-b06d-4378c34488a1/4-of-the-cheapest-biotech-stocks-in-the-world.aspx?yptr=yahoo&.tsrc=rss,All four of these drug stocks have PEG ratios below 1.
JAZZ,JAZZ:UW,BBG000G9DVF3,Edited Transcript of JAZZ earnings conference call or presentation 9-May-17 8:30pm GMT,2017-05-11 01:06:19 +0000,http://finance.yahoo.com/news/edited-transcript-jazz-earnings-conference-030735425.html?.tsrc=rss,Q1 2017 Jazz Pharmaceuticals PLC Earnings Call
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals (JAZZ) Misses Q1 Earnings & Sales,2017-05-10 16:05:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q7ZUBDrZ1s4/jazz-pharmaceuticals-jazz-misses-q1-earnings-sales-cm787231,Jazz Pharmaceuticals Public Limited Company JAZZ reported first quarter 2017 earnings of 1 41 per share which narrowly missed the Zacks Consensus Estimate of 1 42 However adjusted earnings of 1 90 per share including stock based compensation expenses increased 8 from the year
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals (JAZZ) Misses Q1 Earnings & Sales,2017-05-10 13:52:01 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-jazz-misses-q1-135201852.html?.tsrc=rss,"Jazz Pharmaceuticals Public Limited Company (JAZZ) reported first-quarter 2017 earnings of $1.41 per share, which narrowly missed the Zacks Consensus Estimate of $1.42."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz misses Street 1Q forecasts,2017-05-09 22:18:26 +0000,http://finance.yahoo.com/news/jazz-misses-street-1q-forecasts-221826872.html?.tsrc=rss,"On a per-share basis, the Dublin-based company said it had profit of $1.41. Earnings, adjusted for non-recurring costs and stock option expense, were $2.31 per share. The results missed Wall Street expectations. ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharma Reports Lagging First-Quarter Sales, Profits",2017-05-09 20:49:33 +0000,http://finance.yahoo.com/r/a7d44d5b-a7a5-3036-8ba3-bef692e0949a/jazz-pharma-reports-first-quarter-earnings-2017?src=A00220&yptr=yahoo&.tsrc=rss,"Jazz said Tuesday it settled a patent battle with Hikma over its narcolepsy drug Xyrem, but Jazz stock remained flat after hours on lagging first-quarter numbers."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces First Quarter 2017 Financial Results,2017-05-09 20:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-first-quarter-200500480.html?.tsrc=rss,"DUBLIN, May 9, 2017 /PRNewswire/ -- Total Revenues Increased 12% to $376 Million Settled Xyrem Patent Litigation with First ANDA Filer Completed Rolling NDA Submission for Vyxeos (CPX-351) Announced Positive ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Earnings Reaction History: Jazz Pharmaceuticals, Inc., 25.0% Follow-Through Indicator, 2.9% Sensitive",2017-05-09 19:40:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tYXezoE19YI/earnings-reaction-history-jazz-pharmaceuticals-inc-250-follow-through-indicator-29-sensitive-cm786774,Expected Earnings Release 05 09 2017 After hoursExpected Earnings Release 05 09 2017 After hours Avg Extended Hours Dollar Volume 7 855 913Avg Extended Hours Dollar Volume 7 855 913 Jazz Pharmaceuticals Inc JAZZ is due to issue its quarterly earnings report in the
JAZZ,JAZZ:UW,BBG000G9DVF3,"After-Hours Earnings Report for May 9, 2017 :  DIS, PCLN, NVDA, EA, SLF, MCHP, FNV, REG, JAZZ, DOX, ZAYO, TSRO",2017-05-09 18:53:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KSqso8AcVos/after-hours-earnings-report-for-may-9-2017-dis-pcln-nvda-ea-slf-mchp-fnv-reg-jazz-dox-zayo-tsro-cm786723,The following companies are expected to report earnings after hours on 05 09 2017 Visit our Earnings Calendar for a full list of expected earnings releases Walt Disney Company DIS is reporting for the quarter ending March 31 2017 The media company
JAZZ,JAZZ:UW,BBG000G9DVF3,Investor Network: Jazz Pharmaceuticals Plc to Host Earnings Call,2017-05-09 17:45:00 +0000,http://finance.yahoo.com/news/investor-network-jazz-pharmaceuticals-plc-174500087.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Jazz Pharmaceuticals Plc (NASDAQ: JAZZ ) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 4:30 PM Eastern Time. To ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Allergan&apos;s Q1 Sales Expected To Slip As Jazz Pharma Outperforms,2017-05-08 20:28:32 +0000,http://finance.yahoo.com/r/6f1e841d-3f4d-3ef4-82c6-6f5c4bbd28f8/allergans-q1-sales-expected-to-slip-as-jazz-pharma-outperforms?src=A00220&yptr=yahoo&.tsrc=rss,"Allergan and Jazz are expected Tuesday to report growing first-quarter profits, but Allergan is likely to see sales decline for the first time in nine periods."
JAZZ,JAZZ:UW,BBG000G9DVF3,4 Medical Stocks That Could Be Big Winners Next Week,2017-05-05 20:26:31 +0000,http://finance.yahoo.com/news/4-medical-stocks-could-big-202631130.html?.tsrc=rss,"The following originally appeared on Finbox.io Q1'17 Earnings: Strong Growth & Positive Surprises According to Zack’s Investment Research , 358 members of the S&P 500 have reported their quarterly results ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Q1 Earnings: Stock Likely to Disappoint?,2017-05-03 19:51:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v4pnidxCQ0c/jazz-pharma-jazz-q1-earnings-stock-likely-to-disappoint-cm783686,Jazz Pharmaceuticals plc JAZZ is scheduled to report first quarter 2017 results on May 9 after the market closes Jazz s shares have significantly outperformed the Zacks classified Medical Drugs industry so far this year Specifically the stock gained 46 4 during the period while
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Q1 Earnings: Stock Likely to Disappoint?,2017-05-03 14:35:02 +0000,http://finance.yahoo.com/news/jazz-pharma-jazz-q1-earnings-143502669.html?.tsrc=rss,"Jazz Pharmaceuticals plc (JAZZ) is scheduled to report first-quarter 2017 results on May 9, after the market closes."
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Top Biotech Stocks to Buy Now,2017-04-29 17:26:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zMYXyaPW3zo/3-top-biotech-stocks-to-buy-now-cm781666,If you had invested 10 000 in three select biotech stocks three years ago you d now have nearly 98 000 Which three biotech stocks would have made this accomplishment possible Celgene NASDAQ CELG Jazz Pharmaceuticals NASDAQ JAZZ and Vertex Pharmaceuticals
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Top Biotech Stocks to Buy Now,2017-04-29 16:03:00 +0000,http://finance.yahoo.com/r/d462df76-a929-3e0f-a1ea-b8f4cc756912/3-top-biotech-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Biotech stocks Celgene, Jazz Pharmaceuticals, and Vertex Pharmaceuticals are hard to beat."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 2 Study of JZP-110 in Narcolepsy Patients with Excessive Sleepiness,2017-04-26 20:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-positive-results-200500434.html?.tsrc=rss,"DUBLIN, April 26, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced positive efficacy results from the global multicenter study of JZP-110 in adult patients with excessive sleepiness associated with narcolepsy.  Based on the preliminary safety analysis, the most commonly reported adverse events (AEs) in this study were generally consistent with those previously observed in the Phase 2 clinical studies evaluating JZP-110 in narcolepsy.  ""Excessive sleepiness in narcolepsy remains an important unmet medical need, and we believe that the statistically and clinically significant effect observed in this study indicates that JZP-110 could be an important treatment option for patients,"" said Karen Smith, M.D., Ph.D., global head of research and development and chief medical officer of Jazz Pharmaceuticals.  ""Subject to completion of the data analysis and our regulatory discussions with FDA, we expect to submit the JZP-110 NDA for excessive sleepiness in obstructive sleep apnea and narcolepsy in late 2017."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals to Report 2017 First Quarter Financial Results on May 9, 2017",2017-04-25 20:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-report-2017-first-200500328.html?.tsrc=rss,"DUBLIN, April 25, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2017 first quarter financial results on Tuesday, May 9, 2017, after the close of the ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"D-Day For CAPR Today, OMED Hands Out Pink Slips, JAZZ Hits Right Notes...",2017-04-25 02:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0ZyM6Z7-rM0/dday-for-capr-today-omed-hands-out-pink-slips-jazz-hits-right-notes-20170425-00089,"D-Day For CAPR Today, OMED Hands Out Pink Slips, JAZZ Hits Right Notes..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Positive Results from the Phase 2/3 EXPRESS Study of Xyrem in Pediatric Patients with Narcolepsy with Cataplexy,2017-04-24 20:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-positive-results-200500645.html?.tsrc=rss,"DUBLIN, April 24, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive top-line efficacy results from the global, double-blind, placebo-controlled, randomized-withdrawal, ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Could Lilly Outperform These Bigger Rivals On Strong Diabetes Meds?,2017-04-18 18:31:39 +0000,http://finance.yahoo.com/r/7ba7f433-5ab4-3ca3-836f-d13d5b62232a/could-lilly-outperform-these-bigger-rivals-on-strong-diabetes-meds?src=A00220&yptr=yahoo&.tsrc=rss,Eli Lilly is set to outperform bigger drugmakers Novartis and Sanofi in terms of first-quarter diabetes sales.
JAZZ,JAZZ:UW,BBG000G9DVF3,Analysts Predict 11% Gains Ahead For The Holdings of IYH,2017-04-12 14:55:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x-yZxnZPXgo/analysts-predict-11-gains-ahead-for-the-holdings-of-iyh-cm773146,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals, Inc. -- Moody's affirms Jazz Pharma at Ba3; revises outlook to stable from negative",2017-04-11 17:59:08 +0000,http://finance.yahoo.com/r/1a8e5e84-0639-3ae1-8bab-250ce65db465/viewresearchdoc.aspx?docid=PR_364999&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170411_PR_364999&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's affirms Jazz Pharma at Ba3; revises outlook to stable from negative. Global Credit Research- 11 Apr 2017. New York, April 11, 2017-- Moody's Investors Service affirmed the ratings ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,SPDR S&P Pharmaceuticals ETF Experiences Big Outflow,2017-04-10 16:55:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZzMfujBxYEo/spdr-sp-pharmaceuticals-etf-experiences-big-outflow-cm772227,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Pharmaceuticals ETF Symbol XPH where we have detected an approximate 23 5 million dollar outflow that s a 4 8 decrease week over week
JAZZ,JAZZ:UW,BBG000G9DVF3,Time for some game theory: A look at Jazz Pharma’s latest settlement,2017-04-08 15:32:50 +0000,http://finance.yahoo.com/r/ffd28a38-ea87-3118-b045-a86d87e3ac59/Story.aspx?guid=99336B26-1ACB-11E7-8755-9AB7B5C1C318&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares surged 7.6% on the news, but the devil’s in the details."
JAZZ,JAZZ:UW,BBG000G9DVF3,Should You Drop What You're Doing and Buy Jazz Pharmaceuticals Stock?,2017-04-07 20:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ecrW2pN4mxg/should-you-drop-what-youre-doing-and-buy-jazz-pharmaceuticals-stock-cm771583,In December I included Jazz Pharmaceuticals NASDAQ JAZZ in a list of the three top healthcare stocks investors were overlooking At that time I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation Fast forward to
JAZZ,JAZZ:UW,BBG000G9DVF3,Should You Drop What You&apos;re Doing and Buy Jazz Pharmaceuticals Stock?,2017-04-07 19:41:00 +0000,http://finance.yahoo.com/r/58c0e053-ea46-336c-9108-3a56d9e21955/should-you-drop-what-youre-doing-and-buy-jazz-phar.aspx?yptr=yahoo&.tsrc=rss,Jazz&apos;s latest good news makes the biotech stock an even better pick.
JAZZ,JAZZ:UW,BBG000G9DVF3,"This Rival Might Swipe 20% Of Jazz&apos;s Sleep Business, But Stock Perks Up",2017-04-06 20:42:47 +0000,http://finance.yahoo.com/r/2362c90d-e0ba-3558-8959-7a5e0fa3661e/this-rival-might-swipe-20-of-jazzs-sleep-business-but-stock-perks-up?src=A00220A&yptr=yahoo&.tsrc=rss,Jazz stock launched to a nine-month high Thursday after the drugmaker reached a settlement with Hikma Pharmaceuticals.
JAZZ,JAZZ:UW,BBG000G9DVF3,Market Cheers Jazz Pharmaceuticals Patent Settlement,2017-04-06 18:36:00 +0000,http://finance.yahoo.com/r/3b647833-9c74-3182-831e-3f3d877df006/market-cheers-jazz-pharmaceuticals-patent-settlement?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms’ patent dispute.  As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.  Janney Montgomery Scott’s Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Health Care Sector Update for 04/06/2017: JAZZ,AKTX,NVGN",2017-04-06 18:33:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p92Vb12Cf1M/health-care-sector-update-for-04062017-jazzaktxnvgn-cm770983,Top Health Care StocksTop Health Care Stocks JNJ 0 35 JNJ 0 35 PFE 0 07 PFE 0 07 MRK 0 29 MRK 0 29 ABT 0 03 ABT 0 03 AMGN 0 33 AMGN 0 33 Health care stocks were edging higher with the NYSE Health Care Index climbing about 0 2 while shares of health care companies in the S amp P
JAZZ,JAZZ:UW,BBG000G9DVF3,"Bridges Investment Management Inc Buys iShares Core S&P Small-Cap, Vanguard FTSE All World ...",2017-04-06 16:53:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nycbbaafsYY/bridges-investment-management-inc-buys-ishares-core-sp-small-cap-vanguard-ftse-all-world-cm770906,Bridges Investment Management Inc New Purchases GS JAZZ PNC Added Positions IJR VEU IJH GILD HD FB TMO AMZN CELG FDX Reduced Positions BRK B IWF IWD ESRX BRK A UNP AAPL WFC MRK PM Sold Out DVA LMT VFC VMI GM CPB NNN GPS
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Settles 2010 Xyrem Patent Lawsuit,2017-04-06 15:22:00 +0000,http://finance.yahoo.com/r/27121533-e617-3f51-9d09-b2b8243ba04e/jazz-pharma-settles-2010-xyrem-patent-lawsuit-jazz?partner=YahooSA&yptr=yahoo&.tsrc=rss,Jazz Pharmaceuticals stock spiked more than 6% after it settled its long-pending patent litigation.
JAZZ,JAZZ:UW,BBG000G9DVF3,"Trevena, Synergy Lead Biotech Movers",2017-04-06 14:32:00 +0000,http://finance.yahoo.com/r/c21c0489-b0de-3075-8bf2-b8d2be4ac2f4/trevena-synergy-lead-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Positive phase three data was a boon for Trevena, but Synergy's ""Poop Troop"" put pressure on its stock."
JAZZ,JAZZ:UW,BBG000G9DVF3,Stock Futures Turn Cautiously Higher Ahead of Trump-Xi Meeting,2017-04-06 13:54:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T88H9xpXQSY/stock-futures-turn-cautiously-higher-ahead-of-trump-xi-meeting-cm770647,After Wednesday s late sell off across Wall Street stock futures rebounded ahead of Thursday s open on the back of gains in Europe but are only cautiously higher ahead of President Donald Trump s highly anticipated meeting with Chinese president Xi Jinjing in Florida today and Friday s
JAZZ,JAZZ:UW,BBG000G9DVF3,"Pre-Market Most Active for Apr 6, 2017 :  BSBR, MT, MBLY, ZLTQ, BAC, QQQ, XIV, JAZZ, FTR, CHK, SKM, SGYP",2017-04-06 12:53:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q7V6uYCyrlY/pre-market-most-active-for-apr-6-2017-bsbr-mt-mbly-zltq-bac-qqq-xiv-jazz-ftr-chk-skm-sgyp-cm770590,The NASDAQ 100 Pre Market Indicator is up 5 44 to 5 423 96 The total Pre Market volume is currently 7 538 721 shares traded The following are the most active stocks for the pre market session Banco Santander Brasil SA BSBR is 0 15 at 8 21 with 3 284 770 shares
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug,2017-04-06 12:39:37 +0000,http://finance.yahoo.com/r/5b2ee39a-6fcd-3bf6-82d7-84b1cb8a94cd/Story.aspx?guid=C17D5F12-9CDF-4881-A753-F545FD9F64AC&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Jazz Pharmaceuticals PLC shares surged as much as 6.6% in premarket trade on Thursday after the company said it had reached a settlement with Hikma Pharmaceuticals PLC over Hikma's plans for a generic ...
JAZZ,JAZZ:UW,BBG000G9DVF3,European Markets Recovered From Early Weakness,2017-04-06 11:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DGQuwZHXCcI/european-markets-recovered-from-early-weakness-20170406-00893,European Markets Recovered From Early Weakness
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals (JAZZ) Has Jumped To An 8-Month High After Settlement,2017-04-06 09:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NLkshoBygkg/jazz-pharmaceuticals-jazz-has-jumped-to-an-8month-high-after-settlement-20170406-00698,Jazz Pharmaceuticals (JAZZ) Has Jumped To An 8-Month High After Settlement
JAZZ,JAZZ:UW,BBG000G9DVF3,FTSE 100 Dips On Trump Anxiety Ahead Of Crucial Summit,2017-04-06 05:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LBmwDYuATZc/ftse-100-dips-on-trump-anxiety-ahead-of-crucial-summit-20170406-00182,FTSE 100 Dips On Trump Anxiety Ahead Of Crucial Summit
JAZZ,JAZZ:UW,BBG000G9DVF3,Hikma Pharma Reaches Settlement Deal With Jazz For Sodium Oxybate,2017-04-06 02:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4UOitRJDicw/hikma-pharma-reaches-settlement-deal-with-jazz-for-sodium-oxybate-20170406-00073,Hikma Pharma Reaches Settlement Deal With Jazz For Sodium Oxybate
JAZZ,JAZZ:UW,BBG000G9DVF3,"ARLZ Hands Out Pink Slips, JAZZ On A High Note, STDY On Track, TENX Abuzz",2017-04-06 01:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SmO9UTgdtvc/arlz-hands-out-pink-slips-jazz-on-a-high-note-stdy-on-track-tenx-abuzz-20170406-00018,"ARLZ Hands Out Pink Slips, JAZZ On A High Note, STDY On Track, TENX Abuzz"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Reaches Settlement with Hikma Pharmaceuticals Related to Xyrem Patent Litigation,2017-04-05 20:30:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-reaches-settlement-hikma-203000288.html?.tsrc=rss,"DUBLIN, April 5, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that certain of its subsidiaries have entered into agreements with Hikma Pharmaceuticals PLC and related entities (""Hikma"") resolving patent litigation related to Xyrem® (sodium oxybate) oral solution. The litigation, which has been pending in the U.S. District Court for the District of New Jersey since 2010, resulted from the submission by Roxane Laboratories, Inc. (which was subsequently acquired by Hikma) of an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) seeking approval to market a generic version of Xyrem.  In connection with the settlement, Jazz has granted Hikma and its wholly owned subsidiary, West-Ward Pharmaceuticals Corp. (West-Ward), the right to sell an authorized generic (AG) version of Xyrem in the U.S. under the Xyrem New Drug Application (NDA), commencing on January 1, 2023, or earlier under certain circumstances customary for settlement agreements of this nature. The AG product will be marketed through the Xyrem Risk Evaluation and Mitigation Strategy (REMS) program. The initial term of the AG arrangement is six months, and Hikma has the option to continue the sale of the AG product for up to a total of five years."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Completes NDA Filing for Leukemia Drug to FDA,2017-04-04 16:26:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ysLGch3IVFY/jazz-pharma-completes-nda-filing-for-leukemia-drug-to-fda-cm769615,Jazz Pharmaceuticals plc JAZZ recently announced that it has completed the rolling submission of a new drug application NDA to the FDA seeking approval for its experimental candidate Vyxeos cytarabine and daunorubicin liposome injection The product will be used for the treatment of
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Completes NDA Filing for Leukemia Drug to FDA,2017-04-04 14:28:02 +0000,http://finance.yahoo.com/news/jazz-pharma-completes-nda-filing-142802097.html?.tsrc=rss,"Jazz Pharmaceuticals plc (JAZZ) recently announced that it has completed the rolling submission of a new drug application (NDA) to the FDA, seeking approval for its leukemia candidate, Vyxeos."
JAZZ,JAZZ:UW,BBG000G9DVF3,"9:07 am Jazz Pharma announces the completion of a rolling submission of a New Drug Application to the FDA for the approval of Vyxeos, an Investigational Treatment for Acute Myeloid Leukemia",2017-04-03 13:07:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#jazz,"9:07 am Jazz Pharma announces the completion of a rolling submission of a New Drug Application to the FDA for the approval of Vyxeos, an Investigational Treatment for Acute Myeloid Leukemia"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Completes Rolling Submission of New Drug Application for Vyxeos™ (CPX-351), an Investigational Treatment for Acute Myeloid Leukemia",2017-04-03 13:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-completes-rolling-submission-130500956.html?.tsrc=rss,"DUBLIN, April 3, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced the completion on March 31, 2017 of a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of Vyxeos™ (cytarabine and daunorubicin) liposome for injection, an investigational treatment for acute myeloid leukemia (AML), a rapidly progressing and life-threatening blood cancer.  1  The company has requested a priority review for the Vyxeos NDA, which, if granted, would accelerate the expected timing of the FDA's review."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Completes Rolling Submission of New Drug Application for Vyxeos™ (CPX-351), an Investigational Treatment for Acute Myeloid Leukemia",2017-04-03 13:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-completes-rolling-submission-130500956.html,"[PR Newswire] - DUBLIN, April 3, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced the completion on March 31, 2017 of a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of Vyxeos™ (cytarabine and daunorubicin) liposome for injection, an investigational treatment for acute myeloid leukemia (AML), a rapidly progressing and life-threatening blood cancer. 1 The company has requested a priority review for the Vyxeos NDA, which, if granted, would accelerate the expected timing of the FDA's review."
JAZZ,JAZZ:UW,BBG000G9DVF3,Blog Coverage Jazz Pharmaceuticals Inks License Agreement with Nippon Shinyaku,2017-03-31 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-jazz-pharmaceuticals-inks-121500746.html,"[Accesswire] - Upcoming AWS Coverage on REGENXBIO Post-Earnings Results LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. blog coverage looks at the headline from Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) as ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Blog Coverage Jazz Pharmaceuticals Inks License Agreement with Nippon Shinyaku,2017-03-31 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-jazz-pharmaceuticals-inks-121500746.html?.tsrc=rss,"Upcoming AWS Coverage on REGENXBIO Post-Earnings Results LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. blog coverage looks at the headline from Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) as ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Up 7.6% Since Earnings Report: Can It Continue?,2017-03-31 09:00:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-iZtlp4QU4I/jazz-pharma-jazz-up-76-since-earnings-report-can-it-continue-cm768108,A month has gone by since the last earnings report for Jazz Pharmaceuticals PLC JAZZ Shares have added about 7 6 in that time frame outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a pullback Before we
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Up 7.6% Since Earnings Report: Can It Continue?,2017-03-31 07:30:07 +0000,http://finance.yahoo.com/news/jazz-pharma-jazz-7-6-073007465.html?.tsrc=rss,Jazz Pharma (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Up 7.6% Since Earnings Report: Can It Continue?,2017-03-31 07:30:07 +0000,http://finance.yahoo.com/news/jazz-pharma-jazz-7-6-073007465.html,Jazz Pharma (JAZZ) Up 7.6% Since Earnings Report: Can It Continue?
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals and Nippon Shinyaku Enter Into License Agreements for the Development and Commercialization of Defitelio and Vyxeos in Japan,2017-03-30 06:00:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-nippon-shinyaku-enter-060000347.html?.tsrc=rss,"DUBLIN, March 30, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that it has entered into license agreements with Nippon Shinyaku, Co., Ltd. for Defitelio® (defibrotide sodium) and Vyxeos™ (cytarabine and daunorubicin liposome injection), or CPX-351, in Japan.  Under the terms of the agreements, Nippon Shinyaku will receive exclusive rights to develop and commercialize Defitelio and Vyxeos in Japan in return for an upfront payment to Jazz Pharmaceuticals and subsequent payments based on the successful achievement of certain regulatory and commercial milestones.  Jazz Pharmaceuticals will manufacture and supply Defitelio and Vyxeos to Nippon Shinyaku, and will receive revenue based on a percentage of product sales in Japan.  Financial terms of the agreement have not been disclosed.  Commercialization of Defitelio and Vyxeos in Japan is subject to regulatory approval in Japan."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals and Nippon Shinyaku Enter Into License Agreements for the Development and Commercialization of Defitelio and Vyxeos in Japan,2017-03-30 06:00:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-nippon-shinyaku-enter-060000347.html,"[PR Newswire] - DUBLIN, March 30, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that it has entered into license agreements with Nippon Shinyaku, Co., Ltd. for Defitelio® (defibrotide sodium) and Vyxeos™ (cytarabine and daunorubicin liposome injection), or CPX-351, in Japan. Under the terms of the agreements, Nippon Shinyaku will receive exclusive rights to develop and commercialize Defitelio and Vyxeos in Japan in return for an upfront payment to Jazz Pharmaceuticals and subsequent payments based on the successful achievement of certain regulatory and commercial milestones. Jazz Pharmaceuticals will manufacture and supply Defitelio and Vyxeos to Nippon Shinyaku, and will receive revenue based on a percentage of product sales in Japan. Financial terms of the agreement have not been disclosed. Commercialization of Defitelio and Vyxeos in Japan is subject to regulatory approval in Japan."
JAZZ,JAZZ:UW,BBG000G9DVF3,Why You're Smart to Buy Jazz Pharmaceuticals plc,2017-03-24 21:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ez56rhP7WhM/why-youre-smart-to-buy-jazz-pharmaceuticals-plc-cm765485,If you bought shares of Jazz Pharmaceuticals plc NASDAQ JAZZ at the beginning of the year you made a smart decision The company s stock is up more than 30 so far in 2017 Back in December I highlighted Jazz Pharmaceuticals as a top healthcare stock that many investors
JAZZ,JAZZ:UW,BBG000G9DVF3,Why You're Smart to Buy Jazz Pharmaceuticals plc,2017-03-24 20:41:00 +0000,https://www.fool.com/investing/2017/03/24/why-youre-smart-to-buy-jazz-pharmaceuticals-plc.aspx,Why You're Smart to Buy Jazz Pharmaceuticals plc
JAZZ,JAZZ:UW,BBG000G9DVF3,Why You're Smart to Buy Jazz Pharmaceuticals plc,2017-03-24 20:41:00 +0000,http://finance.yahoo.com/r/8e55c09a-d28e-3d3c-9cff-bf9bd5b5033d/why-youre-smart-to-buy-jazz-pharmaceuticals-plc.aspx?yptr=yahoo&.tsrc=rss,More good news could be on the way soon for Jazz Pharmaceuticals.
JAZZ,JAZZ:UW,BBG000G9DVF3,Blog Coverage Stemline Announces Completion of Enrollment for the Stage 3 SL-401 Pivotal Trial,2017-03-24 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-stemline-announces-completion-121500681.html?.tsrc=rss,"Upcoming AWS Coverage on Jazz Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / March 24, 2017 / Active Wall St. blog coverage looks at the headline from Stemline Therapeutics, Inc. (NASDAQ: ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Blog Coverage Stemline Announces Completion of Enrollment for the Stage 3 SL-401 Pivotal Trial,2017-03-24 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-stemline-announces-completion-121500681.html,"[Accesswire] - Upcoming AWS Coverage on Jazz Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / March 24, 2017 / Active Wall St. blog coverage looks at the headline from Stemline Therapeutics, Inc. (NASDAQ: ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Sleep Disorder Drug Positive in Phase III Studies,2017-03-21 17:09:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nRy7WMDYNck/jazz-sleep-disorder-drug-positive-in-phase-iii-studies-cm763601,Jazz Pharmaceuticals plc JAZZ recently announced positive efficacy results from two phase III studies evaluating the safety and efficacy of its lead pipeline candidate JZP 110 for the treatment of excessive sleepiness ES associated with obstructive sleep apnea OSA Jazz s shares
JAZZ,JAZZ:UW,BBG000G9DVF3,"Actinium Pharmaceuticals (ATNM) Receives New Patents, Boosts Its Portfolio",2017-03-21 16:29:51 +0000,http://ir.baystreet.ca/article.aspx?id=536&1490113791,"Actinium Pharmaceuticals (ATNM) Receives New Patents, Boosts Its Portfolio"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Sleep Disorder Drug Positive in Phase III Studies,2017-03-21 14:54:02 +0000,http://finance.yahoo.com/news/jazz-sleep-disorder-drug-positive-145402873.html?.tsrc=rss,Jazz Pharmaceuticals plc (JAZZ) recently announced positive efficacy results from two phase III studies evaluating the safety and efficacy of its lead pipeline candidate JZP-110 for the treatment of excessive sleepiness.
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Sleep Disorder Drug Positive in Phase III Studies,2017-03-21 14:54:02 +0000,http://finance.yahoo.com/news/jazz-sleep-disorder-drug-positive-145402873.html,Jazz Sleep Disorder Drug Positive in Phase III Studies
JAZZ,JAZZ:UW,BBG000G9DVF3,"PTIE Surges After-hours, Valeant Gets FDA Date, JAZZ Hits Right Notes",2017-03-21 02:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i6aAlU_F7EM/ptie-surges-afterhours-valeant-gets-fda-date-jazz-hits-right-notes-20170321-00057,"PTIE Surges After-hours, Valeant Gets FDA Date, JAZZ Hits Right Notes"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Isn't Dozing; Stock Breaks Out On Sleep Apnea Trial,2017-03-20 20:23:12 +0000,http://www.investors.com/news/technology/jazz-pharma-isnt-sleepy-stock-breaks-out-on-sleep-apnea-trial/?src=A00220A,Jazz Pharma Isn't Dozing; Stock Breaks Out On Sleep Apnea Trial
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Isn't Dozing; Stock Breaks Out On Sleep Apnea Trial,2017-03-20 20:23:12 +0000,http://finance.yahoo.com/r/9be27f63-9b97-3f8b-9256-ff47edc6bfb4/jazz-pharma-isnt-sleepy-stock-breaks-out-on-sleep-apnea-trial?src=A00220A&yptr=yahoo&.tsrc=rss,Jazz stock popped to a seven-month high on strong results from a pair of trials in obstructive sleep apnea.
JAZZ,JAZZ:UW,BBG000G9DVF3,Monday's ETF with Unusual Volume: URTH,2017-03-20 19:06:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DLQ-d-DmrNI/mondays-etf-with-unusual-volume-urth-cm763082,The iShares MSCI World ETF URTH is seeing unusually high volume in afternoon trading Monday with over 161 000 shares traded versus three month average volume of about 44 000 Shares of URTH were off about 0 1 on the day Components of that ETF with the highest volume on Monday
JAZZ,JAZZ:UW,BBG000G9DVF3,"Nektar, AMD, Esperion, and More: Here’s Why These Five Stocks Are Surging",2017-03-20 16:42:33 +0000,http://www.insidermonkey.com/blog/nektar-amd-esperion-and-more-heres-why-these-five-stocks-are-surging-567606/,"Nektar, AMD, Esperion, and More: Here’s Why These Five Stocks Are Surging"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Nektar, AMD, Esperion, and More: Here’s Why These Five Stocks Are Surging",2017-03-20 16:42:33 +0000,http://finance.yahoo.com/r/83b3e123-e67b-3a0f-acb2-3949935791b2/nektar-amd-esperion-and-more-heres-why-these-five-stocks-are-surging-567606?yptr=yahoo&.tsrc=rss,"Although the broader markets are relatively calm, five stocks, Nektar Therapeutics (NASDAQ:NKTR), Advanced Micro Devices, Inc. (NASDAQ:AMD), Esperion Therapeutics Inc (NASDAQ:ESPR), Alibaba Group Holding Ltd (NYSE:BABA), and Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) are each surging for various reasons. In this article, let’s uncover why traders are buying and analyze smart money sentiment toward them. At […]"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 3 and TONES 4 Studies of JZP-110 in Patients with Obstructive Sleep Apnea,2017-03-20 13:00:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-positive-results-130000287.html,"[PR Newswire] - DUBLIN, March 20, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced positive efficacy results from two global multicenter studies in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA). JZP-110 demonstrated highly statistically significant differences in the co-primary efficacy endpoints in the TONES 3 study at the 300 mg, 150 mg, 75 mg and 37.5 mg dose arms and in the TONES 4 study in the combined JZP-110 treatment arm (300 mg, 150 mg, and 75 mg doses) compared to placebo. Based on the preliminary safety analysis, the most commonly reported adverse events (AEs) in these studies were consistent with those previously described in the Phase 2 clinical studies evaluating JZP-110 in narcolepsy."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 3 and TONES 4 Studies of JZP-110 in Patients with Obstructive Sleep Apnea,2017-03-20 13:00:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-positive-results-130000287.html?.tsrc=rss,"DUBLIN, March 20, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced positive efficacy results from two global multicenter studies in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA).  JZP-110 demonstrated highly statistically significant differences in the co-primary efficacy endpoints in the TONES 3 study at the 300 mg, 150 mg, 75 mg and 37.5 mg dose arms and in the TONES 4 study in the combined JZP-110 treatment arm (300 mg, 150 mg, and 75 mg doses) compared to placebo.  Based on the preliminary safety analysis, the most commonly reported adverse events (AEs) in these studies were consistent with those previously described in the Phase 2 clinical studies evaluating JZP-110 in narcolepsy."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals (JAZZ) Is Up Sharply On Phase 3 Study Results,2017-03-20 09:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QIIkqD_D_U4/jazz-pharmaceuticals-jazz-is-up-sharply-on-phase-3-study-results-20170320-00644,Jazz Pharmaceuticals (JAZZ) Is Up Sharply On Phase 3 Study Results
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Initiates Phase III Study for Narcolepsy Candidate,2017-03-16 17:05:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UUy6IrK-kII/jazz-initiates-phase-iii-study-for-narcolepsy-candidate-cm761738,Jazz Pharmaceuticals plc JAZZ recently announced the initiation of patient enrollment in a phase III study evaluating the efficacy and safety of its pipeline candidate JZP 258 for the potential treatment of adult narcolepsy patients with cataplexy and excessive daytime sleepiness
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Initiates Phase III Study for Narcolepsy Candidate,2017-03-16 15:20:03 +0000,http://finance.yahoo.com/news/jazz-initiates-phase-iii-study-152003632.html?.tsrc=rss,"Jazz Pharmaceuticals plc (JAZZ) recently announced the initiation of patient enrollment in a phase III study evaluating the efficacy and safety of its pipeline candidate, JZP-258, for the potential treatment of adult narcolepsy patients."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Initiates Phase III Study for Narcolepsy Candidate,2017-03-16 15:20:03 +0000,http://finance.yahoo.com/news/jazz-initiates-phase-iii-study-152003632.html,Jazz Initiates Phase III Study for Narcolepsy Candidate
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258 for the Treatment of Cataplexy and Excessive Daytime Sleepiness in Narcolepsy,2017-03-15 20:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-first-patient-200500546.html,"[PR Newswire] - DUBLIN, March 15, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an investigational oxybate product candidate with 90 percent less sodium content than Xyrem® (sodium oxybate) oral solution, as a potential treatment for cataplexy and excessive daytime sleepiness (EDS) in adult narcolepsy patients. The clinical study will be conducted across approximately 60 centers in the European Union and the United States."
JAZZ,JAZZ:UW,BBG000G9DVF3,JAZZ PHARMACEUTICALS PLC Financials,2017-03-04 18:04:13 +0000,http://finance.yahoo.com/q/is?s=jazz,JAZZ PHARMACEUTICALS PLC Financials
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017",2017-03-02 14:27:16 +0000,http://www.capitalcube.com/blog/index.php/jazz-pharmaceuticals-plc-jazz-us-earnings-analysis-q4-2016-by-the-numbers-march-2-2017/,"Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharma (JAZZ) Q4 Earnings Beat, Sales Miss Estimates",2017-03-01 23:13:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6GGLTKTtdx8/jazz-pharma-jazz-q4-earnings-beat-sales-miss-estimates-cm755097,Jazz Pharmaceuticals Public Limited Company JAZZ reported fourth quarter 2016 earnings of 1 91 per share which beat the Zacks Consensus Estimate of 1 65 However adjused earnings of 2 31 per share including stock based compensation expense declined 4 5 from the year ago
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharma (JAZZ) Q4 Earnings Beat, Sales Miss Estimates",2017-03-01 21:22:09 +0000,http://finance.yahoo.com/news/jazz-pharma-jazz-q4-earnings-212209484.html,"Jazz Pharma (JAZZ) Q4 Earnings Beat, Sales Miss Estimates"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March,2017-03-01 21:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-participation-two-210500671.html,"[PR Newswire] - Matt Young, executive vice president and chief financial officer, will provide an overview of the company and a business and financial update. Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update."
JAZZ,JAZZ:UW,BBG000G9DVF3,Edited Transcript of JAZZ earnings conference call or presentation 28-Feb-17 9:30pm GMT,2017-03-01 02:41:33 +0000,http://finance.yahoo.com/news/edited-transcript-jazz-earnings-conference-024133139.html,Edited Transcript of JAZZ earnings conference call or presentation 28-Feb-17 9:30pm GMT
JAZZ,JAZZ:UW,BBG000G9DVF3,"JAZZ PHARMACEUTICALS PLC Files SEC form 10-K, Annual Report",2017-02-28 23:36:51 +0000,http://biz.yahoo.com/e/170228/jazz10-k.html,"JAZZ PHARMACEUTICALS PLC Files SEC form 10-K, Annual Report"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz beats 4Q profit forecasts,2017-02-28 22:37:42 +0000,http://sg.finance.yahoo.com/news/jazz-beats-4q-profit-forecasts-223742273.html,Jazz beats 4Q profit forecasts
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals PLC Earnings Call scheduled for 4:30 pm ET today,2017-02-28 21:30:00 +0000,http://biz.yahoo.com/cc/2/155682.html,Jazz Pharmaceuticals PLC Earnings Call scheduled for 4:30 pm ET today
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2016 Financial Results,2017-02-28 21:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-full-fourth-210500981.html,"[PR Newswire] - DUBLIN, Feb. 28, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter of 2016 and provided financial guidance for 2017. ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"After-Hours Earnings Report for February 28, 2017 :  CRM, ROST, PANW, UHS, TSRO, JAZZ, AR, DXCM, EPR, LOGM, ACAD, BUFF",2017-02-28 20:37:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yFc_lxio_H4/after-hours-earnings-report-for-february-28-2017-crm-rost-panw-uhs-tsro-jazz-ar-dxcm-epr-logm-acad-buff-cm754414,The following companies are expected to report earnings after hours on 02 28 2017 Visit our Earnings Calendar for a full list of expected earnings releases Salesforce com Inc CRM is reporting for the quarter ending January 31 2017 The computer
JAZZ,JAZZ:UW,BBG000G9DVF3,"Earnings Reaction History: Jazz Pharmaceuticals, Inc., 22.2% Follow-Through Indicator, 2.9% Sensitive",2017-02-28 19:30:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RdzFixQmWpY/earnings-reaction-history-jazz-pharmaceuticals-inc-222-follow-through-indicator-29-sensitive-cm754413,Expected Earnings Release 02 28 2017 After hoursExpected Earnings Release 02 28 2017 After hours Avg Extended Hours Dollar Volume 9 305 897Avg Extended Hours Dollar Volume 9 305 897 Jazz Pharmaceuticals Inc JAZZ is due to issue its quarterly earnings report in the
JAZZ,JAZZ:UW,BBG000G9DVF3,Q4 2016 Jazz Pharmaceuticals PLC Earnings Release - After Market Close,2017-02-28 12:07:04 +0000,http://biz.yahoo.com/research/earncal/20170228.html?t=jazz,Q4 2016 Jazz Pharmaceuticals PLC Earnings Release - After Market Close
JAZZ,JAZZ:UW,BBG000G9DVF3,"Noteworthy ETF Outflows: IHE, MYL, JAZZ, PRGO",2017-02-24 17:52:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ai7W6wG7EUA/noteworthy-etf-outflows-ihe-myl-jazz-prgo-cm752901,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Pharmaceuticals ETF Symbol IHE where we have detected an approximate 30 6 million dollar outflow that s a 4 0 decrease week over week
JAZZ,JAZZ:UW,BBG000G9DVF3,Vetr And Evercore Put Jazz Pharmaceuticals At Buy,2017-02-23 21:20:59 +0000,http://finance.yahoo.com/news/vetr-evercore-put-jazz-pharmaceuticals-212059489.html,Vetr And Evercore Put Jazz Pharmaceuticals At Buy
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Q4 Earnings: Is a Surprise in Store?,2017-02-23 14:50:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iloLklQr6rg/jazz-pharma-jazz-q4-earnings-is-a-surprise-in-store-cm751915,Jazz Pharmaceuticals plc JAZZ is scheduled to report fourth quarter 2016 results on Feb 28 after the market closes Jazz s shares have outperformed the Zacks classified Medical Drugs industry so far this year Specifically the company s stock gained 23 7 during the period while
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Q4 Earnings: Is a Surprise in Store?,2017-02-23 13:57:01 +0000,http://finance.yahoo.com/news/jazz-pharma-jazz-q4-earnings-135701972.html,Jazz Pharma (JAZZ) Q4 Earnings: Is a Surprise in Store?
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals to Report 2016 Fourth Quarter and Full Year Financial Results on February 28, 2017",2017-02-14 21:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-report-2016-fourth-210500634.html,"[PR Newswire] - DUBLIN, Feb. 14, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 fourth quarter and full year financial results on Tuesday, February 28, 2017, ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Top Biotech Stocks to Buy on Sale,2017-02-14 15:28:02 +0000,http://www.fool.com/investing/2017/02/13/3-top-biotech-stocks-to-buy-on-sale.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Biotech Stocks to Buy on Sale
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Top Biotech Stocks to Buy on Sale,2017-02-13 16:21:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nDMezJnJnyQ/3-top-biotech-stocks-to-buy-on-sale-cm747015,How can you know if a biotech stock is a bargain It s not an exact science but one of the best ways to identify biotech bargains is to evaluate companies growth prospects compared with their current stock price and earnings The price to earnings ratio can point out stocks that
JAZZ,JAZZ:UW,BBG000G9DVF3,Bullish Two Hundred Day Moving Average Cross - JAZZ,2017-02-09 18:17:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JFBu-Q5LqBM/bullish-two-hundred-day-moving-average-cross-jazz-cm745647,In trading on Thursday shares of Jazz Pharmaceuticals plc Symbol JAZZ crossed above their 200 day moving average of 128 74 changing hands as high as 129 44 per share Jazz Pharmaceuticals plc shares are currently trading up about 1 5 on the day The chart below shows the one
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Drug Stocks Poised to Beat Earnings Estimates in Q4,2017-02-09 14:20:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R733SkOwjzs/5-drug-stocks-poised-to-beat-earnings-estimates-in-q4-cm745419,A positive earnings picture continues to emerge from the fourth quarter earnings season with both earnings and revenue growth improving compared to recent quarters As of Feb 8 319 S amp P 500 members or 76 3 of the index s total market capitalization had reported results the numbers show
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Drug Stocks Poised to Beat Earnings Estimates in Q4,2017-02-09 12:39:12 +0000,http://finance.yahoo.com/news/5-drug-stocks-poised-beat-123912751.html,5 Drug Stocks Poised to Beat Earnings Estimates in Q4
JAZZ,JAZZ:UW,BBG000G9DVF3,"AGTC On Watch, It's Advantage REGN, No Need For FDA Panel Review For Betrixaban",2017-02-09 04:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/belLj8ylNro/agtc-on-watch-its-advantage-regn-no-need-for-fda-panel-review-for-betrixaban-20170209-00216,"AGTC On Watch, It's Advantage REGN, No Need For FDA Panel Review For Betrixaban"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating JZP-110 for Excessive Sleepiness in Parkinson's Disease,2017-02-08 21:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-first-patient-210500844.html,"[PR Newswire] - DUBLIN, Feb. 8, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110, a selective dopamine and norepinephrine reuptake inhibitor, as a potential treatment for excessive sleepiness (ES) in adult patients with Parkinson's disease. The clinical study will be conducted across approximately 15 centers in the United States. ""Excessive sleepiness is a debilitating symptom of Parkinson's disease, and we are interested in determining whether the wake-promoting effects of JZP-110 could be beneficial in this patient population,"" said Karen Smith, M.D., Ph.D., global head of research and development and chief medical officer of Jazz Pharmaceuticals. The Phase 2 study is a double-blind, placebo-controlled, randomized, multicenter, crossover study evaluating the safety, efficacy and pharmacokinetics of JZP-110 in adult patients with Parkinson's disease and ES. The study is expected to enroll approximately 50 patients."
JAZZ,JAZZ:UW,BBG000G9DVF3,Actinium Pharmaceuticals Is Better Than Celator,2017-02-07 21:45:06 +0000,http://finance.yahoo.com/news/actinium-pharmaceuticals-better-celator-214506953.html,Actinium Pharmaceuticals Is Better Than Celator
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Jazz Pharmaceuticals PLC's Shareholders Didn't Sleep on This 12% Gain in January,2017-02-04 18:31:31 +0000,http://www.fool.com/investing/2017/02/03/why-jazz-pharmaceuticals-plcs-shareholders-didnt-s.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Jazz Pharmaceuticals PLC's Shareholders Didn't Sleep on This 12% Gain in January
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Jazz Pharmaceuticals PLC's Shareholders Didn't Sleep on This 12% Gain in January,2017-02-03 20:40:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g6w3N8ena50/why-jazz-pharmaceuticals-plcs-shareholders-didnt-sleep-on-this-12-gain-in-january-cm743086,Image source Getty Images What happened Shares of Jazz Pharmaceuticals NASDAQ JAZZ an Ireland based specialty drug developer leaped 12 higher during January according to data from S amp P Global Market Intelligence The reason behind the move can be traced to
JAZZ,JAZZ:UW,BBG000G9DVF3,These 3 Biotech Stocks Are Ridiculously Cheap,2017-02-02 13:15:30 +0000,http://www.fool.com/investing/2017/02/01/these-3-biotech-stocks-are-ridiculously-cheap.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Biotech Stocks Are Ridiculously Cheap
JAZZ,JAZZ:UW,BBG000G9DVF3,These 3 Biotech Stocks Are Ridiculously Cheap,2017-02-01 14:33:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xcVkro5NFnA/these-3-biotech-stocks-are-ridiculously-cheap-cm741316,As the merger and acquisition frenzy kicks into overdrive it s becoming harder and harder to find reasonably priced biotech stocks But there are still some bargains to be had in this highflying space Here s why Amgen NASDAQ AMGN Gilead Sciences NASDAQ GILD and
JAZZ,JAZZ:UW,BBG000G9DVF3,Top Healthcare Stocks to Buy in 2017,2017-02-01 13:14:27 +0000,http://www.fool.com/investing/2017/01/31/top-healthcare-stocks-to-buy-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Top Healthcare Stocks to Buy in 2017
JAZZ,JAZZ:UW,BBG000G9DVF3,Top Healthcare Stocks to Buy in 2017,2017-01-31 14:33:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BeuMLYuZmEc/top-healthcare-stocks-to-buy-in-2017-cm740641,The S amp P 500 gained double digits in 2016 but healthcare investors were largely left out in the cold Shares of the Vanguard Health Care ETF NYSEMKT VHT a widely held index fund that focuses on the sector actually declined by more than 2 during the
JAZZ,JAZZ:UW,BBG000G9DVF3,"XPH, JAZZ, LLY, HZNP: Large Outflows Detected at ETF",2017-01-30 17:31:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wup6DXNV_VQ/xph-jazz-lly-hznp-large-outflows-detected-at-etf-cm740205,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Pharmaceuticals ETF Symbol XPH where we have detected an approximate 32 1 million dollar outflow that s a 7 1 decrease week over week
JAZZ,JAZZ:UW,BBG000G9DVF3,The Math Shows IYH Can Go To $169,2017-01-30 15:33:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zp35O6mQrek/the-math-shows-iyh-can-go-to-169-cm740061,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Most Unbelievably Undervalued Biotech Stocks,2017-01-28 13:28:39 +0000,http://www.fool.com/investing/2017/01/27/3-most-unbelievably-undervalued-biotech-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Most Unbelievably Undervalued Biotech Stocks
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Manufacturing Plant Gets Warning,2017-01-27 16:15:00 +0000,http://www.investopedia.com/news/jazz-pharma-gets-fda-warning-uk-plant-jazz/?partner=YahooSA,Jazz Pharmaceuticals Manufacturing Plant Gets Warning
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Most Unbelievably Undervalued Biotech Stocks,2017-01-27 14:34:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5_INDldUJy4/3-most-unbelievably-undervalued-biotech-stocks-cm739169,Finding undervalued biotech stocks isn t as easy as it might seem Many biotechs don t have a product on the market so any attempt at valuation involves a lot of guesswork about pipeline prospects And many biotechs that do have products on the market command high premiums
JAZZ,JAZZ:UW,BBG000G9DVF3,Why Cramer expects nothing good to come of Fitbit,2017-01-24 00:13:44 +0000,http://www.cnbc.com/id/104235448?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104235448,Why Cramer expects nothing good to come of Fitbit
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Biotechs Likely to Be Acquired in 2017,2017-01-22 18:27:36 +0000,http://www.fool.com/investing/2017/01/22/3-biotechs-likely-to-be-acquired-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotechs Likely to Be Acquired in 2017
JAZZ,JAZZ:UW,BBG000G9DVF3,Can Jazz Pharmaceuticals Be a Top Choice for Value Investors?,2017-01-20 16:39:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gdwEkHZtfvE/can-jazz-pharmaceuticals-be-a-top-choice-for-value-investors-cm735986,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Plc: Leads amongst peers with strong fundamentals,2017-01-19 20:34:56 +0000,http://www.capitalcube.com/blog/index.php/jazz-pharmaceuticals-plc-leads-amongst-peers-with-strong-fundamentals/,Jazz Pharmaceuticals Plc: Leads amongst peers with strong fundamentals
JAZZ,JAZZ:UW,BBG000G9DVF3,Can Jazz Pharmaceuticals Be a Top Choice for Value Investors?,2017-01-19 14:50:02 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-top-choice-value-145002044.html,Can Jazz Pharmaceuticals Be a Top Choice for Value Investors?
JAZZ,JAZZ:UW,BBG000G9DVF3,"Gainers & Losers Of The Day: APRI, LIFE, JAZZ, ETRM, BIOC...",2017-01-18 22:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7u2MGVyxp3Y/gainers--losers-of-the-day-apri-life-jazz-etrm-bioc-20170118-01547,"Gainers & Losers Of The Day: APRI, LIFE, JAZZ, ETRM, BIOC..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Rebuffs Concerns Of Generic Sleep Drug Amid Patent Litigation,2017-01-18 21:20:52 +0000,http://www.investors.com/news/technology/jazz-rebuffs-concerns-of-generic-sleepy-drug-amid-patent-litigation/,Jazz Rebuffs Concerns Of Generic Sleep Drug Amid Patent Litigation
JAZZ,JAZZ:UW,BBG000G9DVF3,Wednesday’s Top Biopharma Winners,2017-01-18 16:05:11 +0000,http://finance.yahoo.com/news/wednesday-top-biopharma-winners-160511481.html,Wednesday’s Top Biopharma Winners
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Begins Phase III Study for Label Expansion of Defitelio,2017-01-18 15:40:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ZqECkbmwc0/jazz-begins-phase-iii-study-for-label-expansion-of-defitelio-cm734724,Jazz Pharmaceuticals Public Limited Company JAZZ announced the initiation of a phase III clinical study on its marketed drug Defitelio defibrotide for the potential prevention of veno occlusive disease VOD in high risk adult and pediatric patients Defitelio is currently available
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Biotech Stocks You'll Want to Watch in the 1st Quarter,2017-01-18 15:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s7SS7YvQFaE/5-biotech-stocks-youll-want-to-watch-in-the-1st-quarter-cm734690,This year is starting off with a bang for several biotechs There s a lot going on from important clinical updates to regulatory decisions Here s why Amgen NASDAQ AMGN Jazz Pharmaceuticals NASDAQ JAZZ Lexicon Pharmaceuticals NASDAQ LXRX
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Biotech Stocks You'll Want to Watch in the 1st Quarter,2017-01-18 14:26:33 +0000,http://www.fool.com/investing/2017/01/18/5-biotech-stocks-youll-want-to-watch-in-the-1st-qu.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Biotech Stocks You'll Want to Watch in the 1st Quarter
JAZZ,JAZZ:UW,BBG000G9DVF3,FDA Approves Generic of Jazz Pharma's Sleep Drug,2017-01-18 14:15:00 +0000,http://www.investopedia.com/news/fda-approves-generic-jazzs-sleep-drug-jazz/?partner=YahooSA,FDA Approves Generic of Jazz Pharma's Sleep Drug
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Begins Phase III Study for Label Expansion of Defitelio,2017-01-18 13:44:01 +0000,http://finance.yahoo.com/news/jazz-begins-phase-iii-study-134401535.html,Jazz Begins Phase III Study for Label Expansion of Defitelio
JAZZ,JAZZ:UW,BBG000G9DVF3,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events",2017-01-18 11:10:11 +0000,http://biz.yahoo.com/e/170118/jazz8-k.html,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals (JAZZ) Has Climbed To Over A 3-Month High,2017-01-18 09:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gRbRAQFouKY/jazz-pharmaceuticals-jazz-has-climbed-to-over-a-3month-high-20170118-00741,Jazz Pharmaceuticals (JAZZ) Has Climbed To Over A 3-Month High
JAZZ,JAZZ:UW,BBG000G9DVF3,Hikma's Unit Roxane Gets US Approval For Generic Sodium Oxybate Oral Solution,2017-01-18 05:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pjw7VywPTLU/hikmas-unit-roxane-gets-us-approval-for-generic-sodium-oxybate-oral-solution-20170118-00168,Hikma's Unit Roxane Gets US Approval For Generic Sodium Oxybate Oral Solution
JAZZ,JAZZ:UW,BBG000G9DVF3,"ADHD Doesn't MEASURE Up, JAZZ Abuzz, NBIX Slips On Failed Study",2017-01-18 02:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VJpUu1hzaR8/adhd-doesnt-measure-up-jazz-abuzz-nbix-slips-on-failed-study-20170118-00069,"ADHD Doesn't MEASURE Up, JAZZ Abuzz, NBIX Slips On Failed Study"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Neurocrine Med Failure, Jazz Pharma Generic Rival OK Sends Both Down",2017-01-17 22:28:37 +0000,http://www.investors.com/news/technology/pharma-stocks-topple-late-after-neurocrines-tourette-med-fails/,"Neurocrine Med Failure, Jazz Pharma Generic Rival OK Sends Both Down"
JAZZ,JAZZ:UW,BBG000G9DVF3,FDA approves generic version of Jazz Pharma's sleep disorder drug,2017-01-17 22:16:52 +0000,http://finance.yahoo.com/news/fda-approves-generic-version-jazz-221652686.html,"[Reuters] - The U.S. Food and Drug Administration said on Tuesday it had approved the first generic version of Xyrem, Jazz Pharmaceuticals Plc's drug to treat patients with a medical condition that causes excessive ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating Defibrotide for the Potential Prevention of VOD in High Risk Patients,2017-01-17 21:02:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-first-patient-210200693.html,"[PR Newswire] - DUBLIN, Jan. 17, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 3 clinical trial comparing the efficacy and safety of defibrotide ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,9 Stocks Trading Below the Peter Lynch Value,2017-01-11 20:21:48 +0000,http://finance.yahoo.com/news/9-stocks-trading-below-peter-202148232.html,9 Stocks Trading Below the Peter Lynch Value
JAZZ,JAZZ:UW,BBG000G9DVF3,Blog Coverage Alexion Pharma Applies for US and EU Marketing Approval of Refractory Generalized Myasthenia Gravis Medicine,2017-01-10 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-alexion-pharma-applies-131500419.html,"[Accesswire] - Upcoming AWS Coverage on Jazz Pharmaceuticals LONDON, UK / ACCESSWIRE / January 10, 2017 / Active Wall St. blog coverage looks at the headline from Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) as the ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and",2017-01-09 22:00:16 +0000,http://biz.yahoo.com/e/170109/jazz8-k.html,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and"
JAZZ,JAZZ:UW,BBG000G9DVF3,Start the New Year off Right with 3 Best Biotech Stocks,2017-01-09 16:11:34 +0000,http://www.fool.com/investing/2017/01/08/start-the-new-year-off-right-with-3-best-biotech-s.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Start the New Year off Right with 3 Best Biotech Stocks
JAZZ,JAZZ:UW,BBG000G9DVF3,Start the New Year off Right with 3 Best Biotech Stocks,2017-01-08 17:49:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H8BiRk_zAyw/start-the-new-year-off-right-with-3-best-biotech-stocks-cm730824,Many Americans start off each new year by heading to the gym That s a great idea but the enthusiasm soon fades away and the crowded gyms of January turn into the wide open spaces of February Here s another way to start the new year off right that has more staying power Buy
JAZZ,JAZZ:UW,BBG000G9DVF3,Here's Why Jazz Pharmaceuticals PLC Fell Out of Tune and Lost 22% in 2016,2017-01-05 16:44:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IqYjQBpNQvo/heres-why-jazz-pharmaceuticals-plc-fell-out-of-tune-and-lost-22-in-2016-cm729840,Image source Getty Images What happened Shares of Jazz Pharmaceuticals NASDAQ JAZZ an Ireland based specialty drugmaker tumbled 22 in 2016 according to S amp P Global Market Intelligence which was an even worse performance than specialty drugmakers as a
JAZZ,JAZZ:UW,BBG000G9DVF3,Here's Why Jazz Pharmaceuticals PLC Fell Out of Tune and Lost 22% in 2016,2017-01-05 15:26:06 +0000,http://www.fool.com/investing/2017/01/05/heres-why-jazz-pharmaceuticals-plc-fell-out-of-tun.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Jazz Pharmaceuticals PLC Fell Out of Tune and Lost 22% in 2016
JAZZ,JAZZ:UW,BBG000G9DVF3,Industrial Companies Showing Good Potential for 2017,2017-01-04 22:49:46 +0000,http://finance.yahoo.com/news/industrial-companies-showing-good-potential-224946684.html,Industrial Companies Showing Good Potential for 2017
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 9,2017-01-03 21:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-present-j-p-210500680.html,"[PR Newswire] - DUBLIN, Jan. 3, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that the company will be webcasting its corporate presentation at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and provide a business and financial update at the conference on Monday, January 9, 2017 at 9:00 a.m. PST / 5:00 p.m. GMT. A live audio webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast."
JAZZ,JAZZ:UW,BBG000G9DVF3,4 Top Stocks on Sale This Winter,2017-01-02 15:59:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o00ygo_lkwM/4-top-stocks-on-sale-this-winter-cm728374,Image source Getty Images The snow may be falling but optimism is riding high for Wall Street and investors as we dive headlong into a new year What began with a whimper in 2016 ended with a bang In less than two months since the election the iconic Dow Jones Industrial
JAZZ,JAZZ:UW,BBG000G9DVF3,4 Top Stocks on Sale This Winter,2017-01-02 14:03:00 +0000,http://www.fool.com/investing/2017/01/02/4-top-stocks-on-sale-this-winter.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,4 Top Stocks on Sale This Winter
JAZZ,JAZZ:UW,BBG000G9DVF3,Gurus and Insiders Invest in Industrial and Medical Companies,2016-12-30 22:16:00 +0000,http://finance.yahoo.com/news/gurus-insiders-invest-industrial-medical-221600592.html,Gurus and Insiders Invest in Industrial and Medical Companies
JAZZ,JAZZ:UW,BBG000G9DVF3,First Week of February 2017 Options Trading For Jazz Pharmaceuticals (JAZZ),2016-12-27 17:57:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J1mOY2ZW1Zw/first-week-of-february-2017-options-trading-for-jazz-pharmaceuticals-jazz-cm726536,Investors in Jazz Pharmaceuticals plc Symbol JAZZ saw new options become available this week for the February 2017 expiration At Stock Options Channel our YieldBoost formula has looked up and down the JAZZ options chain for the new February 2017 contracts and identified one put and one
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc – Value Analysis (NASDAQ:JAZZ) : December 27, 2016",2016-12-27 15:54:25 +0000,http://www.capitalcube.com/blog/index.php/jazz-pharmaceuticals-plc-value-analysis-nasdaqjazz-december-27-2016/,"Jazz Pharmaceuticals Plc – Value Analysis (NASDAQ:JAZZ) : December 27, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : December 26, 2016",2016-12-26 12:33:06 +0000,http://www.capitalcube.com/blog/index.php/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bullish-manner-jazz-us-december-26-2016/,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : December 26, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,What Are Analysts Saying about Horizon Pharma?,2016-12-21 15:35:45 +0000,http://marketrealist.com/2016/12/what-are-analysts-saying-about-horizon-pharma/?utm_source=yahoo&utm_medium=feed,What Are Analysts Saying about Horizon Pharma?
JAZZ,JAZZ:UW,BBG000G9DVF3,The Best Biopharma CEOs of 2016 Are...,2016-12-19 14:10:00 +0000,https://www.thestreet.com/story/13930531/1/the-best-biopharma-ceos-of-2016-are.html?puc=yahoo&cm_ven=YAHOO,The Best Biopharma CEOs of 2016 Are...
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Top Healthcare Stocks You've Been Overlooking,2016-12-18 13:57:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FRAYY5-U1C0/3-top-healthcare-stocks-youve-been-overlooking-cm722959,Big pharma and big biotech stocks get most of the attention in the healthcare sector However there are plenty of other opportunities that hold the potential to bring great returns to investors Here are three healthcare stocks that you might be overlooking Align Technology
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Top Healthcare Stocks You've Been Overlooking,2016-12-18 12:06:10 +0000,http://www.fool.com/investing/2016/12/18/3-top-healthcare-stocks-youve-been-overlooking.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Healthcare Stocks You've Been Overlooking
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETFs with exposure to Jazz Pharmaceuticals Plc : December 16, 2016",2016-12-16 18:56:22 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-jazz-pharmaceuticals-plc-december-16-2016/,"ETFs with exposure to Jazz Pharmaceuticals Plc : December 16, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,Hedge Funds Aren’t Letting Their Money Stay At Wyndham Worldwide Corporation (WYN),2016-12-07 18:49:39 +0000,http://www.insidermonkey.com/blog/hedge-funds-arent-letting-their-money-stay-at-wyndham-worldwide-corporation-wyn-500940/,Hedge Funds Aren’t Letting Their Money Stay At Wyndham Worldwide Corporation (WYN)
JAZZ,JAZZ:UW,BBG000G9DVF3,Hedge Funds Are Dumping Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ),2016-12-07 12:29:57 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-dumping-jazz-pharmaceuticals-plc-ordinary-shares-jazz-499789/,Hedge Funds Are Dumping Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ)
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETFs with exposure to Jazz Pharmaceuticals Plc : December 5, 2016",2016-12-05 17:16:26 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-jazz-pharmaceuticals-plc-december-5-2016/,"ETFs with exposure to Jazz Pharmaceuticals Plc : December 5, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial,2016-11-29 14:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WWAr7tugltA/jazz-completes-patient-enrollment-in-jzp-110-narcolepsy-trial-cm714950,Jazz Pharmaceuticals Public Limited Company JAZZ announced that its phase III study evaluating JZP 110 has completed patient enrollment The study is evaluating JZP 110 for the treatment of excessive sleepiness ES associated with narcolepsy The phase III narcolepsy study is a double
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial,2016-11-29 12:51:12 +0000,http://finance.yahoo.com/news/jazz-completes-patient-enrollment-jzp-125112262.html,Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial
JAZZ,JAZZ:UW,BBG000G9DVF3,"FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX",2016-11-29 00:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_blUfWqs7IM/fold-shrinks-jazz-on-right-track-nvls-choked-up-aaap-on-watch-nvro-sues-bsx-20161129-00005,"FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Study of JZP-110 Evaluating Excessive Sleepiness in Narcolepsy,2016-11-28 21:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-announces-patient-enrollment-210500881.html,"[PR Newswire] - DUBLIN, Nov. 28, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that patient enrollment has been completed in its Phase 3 study evaluating JZP-110 in excessive sleepiness (ES) associated with narcolepsy. The Phase 3 narcolepsy study was a double-blind, placebo-controlled, multiple-center study evaluating the safety and efficacy of JZP-110 in the treatment of ES in adult patients with narcolepsy. The study enrolled 240 patients. The co-primary endpoints were the Maintenance of Wakefulness Test and the Epworth Sleepiness Scale. These are validated endpoints, commonly used in clinical trials, that measure the ability to stay awake and the severity of excessive sleepiness, respectively, in patients."
JAZZ,JAZZ:UW,BBG000G9DVF3,Gurus Invest in Undervalued Biotech Stocks,2016-11-25 18:14:55 +0000,http://finance.yahoo.com/news/gurus-invest-undervalued-biotech-stocks-181455873.html,Gurus Invest in Undervalued Biotech Stocks
JAZZ,JAZZ:UW,BBG000G9DVF3,Blog Coverage Gilead Sciences Hepatitis B Drug Vemlidy Approved by European Medicines Agency,2016-11-14 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-gilead-sciences-hepatitis-131500057.html,"[Accesswire] - Upcoming AWS Coverage on Jazz Pharma Post-Earnings Results LONDON, UK / ACCESSWIRE / November 14, 2016 / Active Wall St. blog coverage looks at the headline from Gilead Sciences, Inc. (NASDAQ: GILD ) as ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences,2016-11-10 21:21:16 +0000,http://www.publicnow.com/view/C2248CE8465DDDCB37D0C30D802D5D50580B989C,"[at noodls] - DUBLIN, Nov. 10, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at three upcoming investor conferences. ... ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETF’s with exposure to Jazz Pharmaceuticals Plc : November 10, 2016",2016-11-10 17:36:46 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-jazz-pharmaceuticals-plc-november-10-2016/,"ETF’s with exposure to Jazz Pharmaceuticals Plc : November 10, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharma (JAZZ) Q3 Earnings Top, Sales Lag Estimates",2016-11-09 15:56:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CUw38JfH-PE/jazz-pharma-jazz-q3-earnings-top-sales-lag-estimates-cm706427,Jazz Pharmaceuticals Public Limited Company JAZZ reported third quarter 2016 earnings of 2 16 per share including stock based compensation expense which surpassed the Zacks Consensus Estimate of 1 57 Earnings were however almost unchanged from the year ago tally Excluding stock
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016",2016-11-09 15:04:39 +0000,http://www.capitalcube.com/blog/index.php/jazz-pharmaceuticals-plc-jazz-us-earnings-analysis-q3-2016-by-the-numbers-november-9-2016/,"Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,The Market In 5 Minutes: Trump Victory Spooks Stocks,2016-11-09 14:07:55 +0000,http://finance.yahoo.com/news/market-5-minutes-trump-victory-140755331.html,The Market In 5 Minutes: Trump Victory Spooks Stocks
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Sectors Poised to Benefit From Donald Trump's Victory,2016-11-09 13:54:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n0crDvr3L5E/5-sectors-poised-to-benefit-from-donald-trumps-victory-cm706208,Image source Disney ABC Television Group via Flickr What can arguably called the craziest election on American soil is officially over Unfortunately the smoke hasn t quite cleared after Donald Trump was named the president elect Wall Street had been predicting victory for
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharma (JAZZ) Q3 Earnings Top, Sales Lag Estimates",2016-11-09 13:48:01 +0000,http://finance.yahoo.com/news/jazz-pharma-jazz-q3-earnings-134801690.html,"Jazz Pharma (JAZZ) Q3 Earnings Top, Sales Lag Estimates"
JAZZ,JAZZ:UW,BBG000G9DVF3,5 Sectors Poised to Benefit From Donald Trump's Victory,2016-11-09 12:10:41 +0000,http://www.fool.com/investing/2016/11/09/5-sectors-poised-to-benefit-from-donald-trumps-vic.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Sectors Poised to Benefit From Donald Trump's Victory
JAZZ,JAZZ:UW,BBG000G9DVF3,Edited Transcript of JAZZ earnings conference call or presentation 8-Nov-16 9:30pm GMT,2016-11-09 07:39:31 +0000,http://finance.yahoo.com/news/edited-transcript-jazz-earnings-conference-073931400.html,Edited Transcript of JAZZ earnings conference call or presentation 8-Nov-16 9:30pm GMT
JAZZ,JAZZ:UW,BBG000G9DVF3,"After-Hours Earnings Report for November 8, 2016 :  CXO, DOX, TRIP, ZAYO, ASH, JAZZ, VSAT, CPA, CVG, PSEC, PFGC, ILG",2016-11-08 22:39:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8kgAyL6A3Fg/after-hours-earnings-report-for-november-8-2016-cxo-dox-trip-zayo-ash-jazz-vsat-cpa-cvg-psec-pfgc-ilg-cm705771,The following companies are expected to report earnings after hours on 11 08 2016 Visit our Earnings Calendar for a full list of expected earnings releases Concho Resources Inc CXO is reporting for the quarter ending September 30 2016 The oil us exp
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Stock Retreats as Q3 Falls Short,2016-11-08 22:33:00 +0000,https://www.thestreet.com/story/13885779/1/jazz-pharmaceuticals-stock-retreats-as-q3-falls-short.html?puc=yahoo&cm_ven=YAHOO,Jazz Pharmaceuticals Stock Retreats as Q3 Falls Short
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals PLC Earnings Call scheduled for 4:30 pm ET today,2016-11-08 21:30:00 +0000,http://biz.yahoo.com/cc/8/154488.html,Jazz Pharmaceuticals PLC Earnings Call scheduled for 4:30 pm ET today
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Third Quarter 2016 Financial Results,2016-11-08 21:19:14 +0000,http://www.publicnow.com/view/528EAE1B2BD13CE0451D655A7CB082756C9BFDE6,"[at noodls] - DUBLIN, Nov. 8, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2016 and updated financial guidance for 2016. ... This is an abstract ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz misses Street 3Q forecasts,2016-11-08 21:16:52 +0000,http://sg.finance.yahoo.com/news/jazz-misses-street-3q-forecasts-211652843.html,Jazz misses Street 3Q forecasts
JAZZ,JAZZ:UW,BBG000G9DVF3,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and",2016-11-08 21:12:33 +0000,http://biz.yahoo.com/e/161108/jazz8-k.html,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and"
JAZZ,JAZZ:UW,BBG000G9DVF3,2 Stocks to Watch After the Market Closes on Election Day,2016-11-08 13:40:29 +0000,http://finance.yahoo.com/tumblr/blog-2-stocks-to-watch-after-the-market-closes-on-134034432.html,2 Stocks to Watch After the Market Closes on Election Day
JAZZ,JAZZ:UW,BBG000G9DVF3,Q3 2016 Jazz Pharmaceuticals PLC Earnings Release - After Market Close,2016-11-08 12:07:08 +0000,http://biz.yahoo.com/research/earncal/20161108.html?t=jazz,Q3 2016 Jazz Pharmaceuticals PLC Earnings Release - After Market Close
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals to Present New Data at the Annual ASH Meeting,2016-11-07 21:05:00 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-present-data-annual-210500393.html,"[PR Newswire] - DUBLIN, Nov. 7, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that eleven abstracts, including four oral presentations, supporting the company's hematology and oncology portfolio ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Drug Stock Earnings to Watch on Nov 8: JAZZ, VRX, TBPH, OPHT",2016-11-07 12:52:12 +0000,http://finance.yahoo.com/news/drug-stock-earnings-watch-nov-125212881.html,"Drug Stock Earnings to Watch on Nov 8: JAZZ, VRX, TBPH, OPHT"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Trader's Daily Notebook: For a Decline, It Sure Was Smooth",2016-11-04 11:00:00 +0000,http://realmoney.thestreet.com/articles/11/04/2016/traders-daily-notebook-decline-it-sure-was-smooth?puc=yahoo&cm_ven=YAHOO,"Trader's Daily Notebook: For a Decline, It Sure Was Smooth"
JAZZ,JAZZ:UW,BBG000G9DVF3,Pricing Concerns Push Jazz Pharmaceuticals PLC Down 10% in October,2016-11-02 19:08:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jb8j2uVn2E8/pricing-concerns-push-jazz-pharmaceuticals-plc-down-10-in-october-cm702727,Image source Getty Images What happened Shares of Jazz Pharmaceuticals PLC NASDAQ JAZZ an Irish based biopharmaceutical company primarily focused on the development of therapies to treat sleep disorders fell 10 in October based on data from S amp P Global
JAZZ,JAZZ:UW,BBG000G9DVF3,Pricing Concerns Push Jazz Pharmaceuticals PLC Down 10% in October,2016-11-02 17:54:34 +0000,http://www.fool.com/investing/2016/11/02/pricing-concerns-push-jazz-pharmaceuticals-plc-dow.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pricing Concerns Push Jazz Pharmaceuticals PLC Down 10% in October
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Q3 Earnings: A Disappointment in Store?,2016-11-01 14:19:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8yJ_3K-hM3s/jazz-pharma-jazz-q3-earnings-a-disappointment-in-store-cm701576,Jazz Pharmaceuticals plc JAZZ is scheduled to report third quarter 2016 results on Nov 8 after the market closes Last quarter the company had comfortably surpassed expectations with a positive earnings surprise of 5 26 Jazz s track record is quite encouraging with the company
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma (JAZZ) Q3 Earnings: A Disappointment in Store?,2016-11-01 12:32:12 +0000,http://finance.yahoo.com/news/jazz-pharma-jazz-q3-earnings-123212721.html,Jazz Pharma (JAZZ) Q3 Earnings: A Disappointment in Store?
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals to Report 2016 Third Quarter Financial Results on November 8, 2016",2016-10-25 20:15:07 +0000,http://www.publicnow.com/view/E22F9272CAC6572D8DAB755E2DDF084504E69AE7,"[at noodls] - DUBLIN, Oct. 25, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 third quarter financial results on Tuesday, November 8, 2016, after the close ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Top 5 valuable Pharma stocks : October 24, 2016",2016-10-24 17:35:49 +0000,http://www.capitalcube.com/blog/index.php/top-5-valuable-pharma-stocks-october-24-2016/,"Top 5 valuable Pharma stocks : October 24, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Healthcare Stocks That Are Looking Cheap,2016-10-21 14:03:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9ecvH0-oAu8/3-healthcare-stocks-that-are-looking-cheap-cm696340,Image source Getty Images Investors focused on the healthcare sector seem to be getting scared and it s not even Halloween yet Healthcare stocks have taken a beating recently But remember what Warren Buffett once famously said Be fearful when others are greedy and be
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Healthcare Stocks That Are Looking Cheap,2016-10-20 14:52:50 +0000,http://www.fool.com/investing/2016/10/20/3-healthcare-stocks-that-are-looking-cheap.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Healthcare Stocks That Are Looking Cheap
JAZZ,JAZZ:UW,BBG000G9DVF3,These Are US Hedge Funds’ Favorite European Stocks,2016-10-09 17:12:59 +0000,http://www.insidermonkey.com/blog/these-are-us-hedge-funds-favorite-european-stocks-474400/,These Are US Hedge Funds’ Favorite European Stocks
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Initiates Rolling NDA for Leukemia Candidate Vyxeos,2016-10-04 14:46:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eHgAhRLrZZs/jazz-initiates-rolling-nda-for-leukemia-candidate-vyxeos-cm688509,Jazz Pharmaceuticals plc JAZZ announced that it has started the submission of a rolling New Drug Application NDA to the FDA seeking an approval for its experimental candidate Vyxeos for the treatment of acute myeloid leukemia AML The submission is expected to be complete by early
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Initiates Rolling NDA for Leukemia Candidate Vyxeos,2016-10-04 13:12:01 +0000,http://finance.yahoo.com/news/jazz-initiates-rolling-nda-leukemia-131201159.html,Jazz Initiates Rolling NDA for Leukemia Candidate Vyxeos
JAZZ,JAZZ:UW,BBG000G9DVF3,"DVAX Back In News, Spectral Shock For Investors, MACK Giving Pink Slips",2016-10-04 02:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3nmMaJMaPw8/dvax-back-in-news-spectral-shock-for-investors-mack-giving-pink-slips-20161004-00056,"DVAX Back In News, Spectral Shock For Investors, MACK Giving Pink Slips"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Initiates Rolling NDA Submission for Vyxeos (CPX-351) Expects to Complete NDA Submission by Early 2017,2016-10-03 12:46:03 +0000,http://www.publicnow.com/view/D09E2E92D4B6AFF3AA0F5F876FD2721526972AB7,"[at noodls] - DUBLIN, Oct. 3, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq; JAZZ) today announced the initiation of a rolling submission of a New Drug Application (NDA) to the United States (U.S.) Food and ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Closes Enrollment in OSA Drug Phase III Trial,2016-09-28 16:25:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NloC6mcTzi8/jazz-pharma-closes-enrollment-in-osa-drug-phase-iii-trial-cm686027,Jazz Pharmaceuticals Public Limited Company JAZZ announced the completion of patient enrollment in two phase III studies evaluating the safety and efficacy of its lead pipeline candidate JZP 110 for the treatment of excessive sleepiness ES associated with obstructive sleep apnea OSA
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma Closes Enrollment in OSA Drug Phase III Trial,2016-09-28 14:05:02 +0000,http://finance.yahoo.com/news/jazz-pharma-closes-enrollment-osa-140502806.html,Jazz Pharma Closes Enrollment in OSA Drug Phase III Trial
JAZZ,JAZZ:UW,BBG000G9DVF3,Goldman Sachs: Pharma Stocks That Need Price Hikes to Thrive Better Find a New Strategy Fast,2016-09-27 17:30:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/27/goldman-sachs-pharma-stocks-that-need-price-hikes-to-thrive-better-find-a-new-strategy-fast/?mod=yahoobarrons&ru=yahoo,Goldman Sachs: Pharma Stocks That Need Price Hikes to Thrive Better Find a New Strategy Fast
JAZZ,JAZZ:UW,BBG000G9DVF3,The Drug Price Increase Debate: Separating The Winners From The Losers,2016-09-27 15:23:28 +0000,http://finance.yahoo.com/news/drug-price-increase-debate-separating-152328816.html,The Drug Price Increase Debate: Separating The Winners From The Losers
JAZZ,JAZZ:UW,BBG000G9DVF3,"ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial",2016-09-27 02:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KUQnhvR44UY/arry-hits-columbus-goals-kite-flies-afterhrs-fda-places-hold-on-cvm-trial-20160927-00041,"ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial"
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Top Biotech Stocks to Buy on Sale,2016-09-26 20:25:44 +0000,http://www.fool.com/investing/2016/09/26/3-top-biotech-stocks-to-buy-on-sale.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Biotech Stocks to Buy on Sale
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Studies of JZP-110 Evaluating Excessive Sleepiness in Obstructive Sleep Apnea,2016-09-26 20:19:08 +0000,http://www.publicnow.com/view/ECFB832A7C7E074CE45BF2A25D347979018C1215,"[at noodls] - DUBLIN, Sept. 26, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that patient enrollment has been completed for its two Phase 3 studies evaluating JZP-110 in excessive sleepiness ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Top Biotech Stocks to Buy on Sale,2016-09-26 14:24:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9snXci0A7dY/3-top-biotech-stocks-to-buy-on-sale-cm684420,Image source Getty Images Investors looking for growth opportunities often like what they find in the biotech sector Unfortunately biotech stocks frequently come with valuations that are either sky high or highly speculative The good news though is that there are some
JAZZ,JAZZ:UW,BBG000G9DVF3,The Cheapest Stocks in Biotech,2016-09-23 18:59:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_RnC68qjFBI/the-cheapest-stocks-in-biotech-cm683664,Image source Getty Images Biotech is without question the biggest roll of the dice industry you can choose to invest in Over 90 of publicly traded biotech stocks are expected to lose money in 2017 and the vast majority of discovery preclinical and clinical studies end
JAZZ,JAZZ:UW,BBG000G9DVF3,Peek Under The Hood: XPH Has 25% Upside,2016-09-23 14:21:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Txe4vJIQY8Q/peek-under-the-hood-xph-has-25-upside-cm683722,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
JAZZ,JAZZ:UW,BBG000G9DVF3,The Cheapest Stocks in Biotech,2016-09-23 13:07:12 +0000,http://www.fool.com/investing/2016/09/23/the-cheapest-stocks-in-biotech.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Cheapest Stocks in Biotech
JAZZ,JAZZ:UW,BBG000G9DVF3,Next Year Setting Up To Be Smooth For Jazz Pharmaceuticals,2016-09-21 17:04:13 +0000,http://finance.yahoo.com/news/next-setting-smooth-jazz-pharmaceuticals-170413861.html,Next Year Setting Up To Be Smooth For Jazz Pharmaceuticals
JAZZ,JAZZ:UW,BBG000G9DVF3,How Analysts See Horizon Compared to Its Peers,2016-09-21 15:05:03 +0000,http://marketrealist.com/2016/09/how-analysts-see-horizon-compared-to-its-peers/?utm_source=yahoo&utm_medium=feed,How Analysts See Horizon Compared to Its Peers
JAZZ,JAZZ:UW,BBG000G9DVF3,Understanding Valeant’s Improved Valuation Multiple,2016-09-19 16:59:52 +0000,http://marketrealist.com/2016/09/understanding-valeants-improved-valuation-multiple/?utm_source=yahoo&utm_medium=feed,Understanding Valeant’s Improved Valuation Multiple
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference,2016-09-17 09:38:10 +0000,http://www.publicnow.com/view/573E6417913ADE146E94DA32B28AA85FBE54A2E8,"[at noodls] - DUBLIN, Sept. 7, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the Morgan Stanley Global Healthcare Conference ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Mid-Cap Healthcare Stocks You Can Buy Right Now,2016-09-10 17:29:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QjdQSsBmGQk/3-mid-cap-healthcare-stocks-you-can-buy-right-now-cm677402,Image source Getty Images Many investors prefer large cap stocks as the underlying companies tend to be mature and stable However it s a mistake to overlook mid cap stocks which 160 are generally defined as having a market capitalization of between 2 billion and 10
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Mid-Cap Healthcare Stocks You Can Buy Right Now,2016-09-10 16:09:56 +0000,http://www.fool.com/investing/2016/09/10/3-mid-cap-healthcare-stocks-you-can-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Mid-Cap Healthcare Stocks You Can Buy Right Now
JAZZ,JAZZ:UW,BBG000G9DVF3,Halvorsen Bought 13 New Holdings in 2nd Quarter,2016-09-08 22:53:47 +0000,http://finance.yahoo.com/news/halvorsen-bought-13-holdings-2nd-225347031.html,Halvorsen Bought 13 New Holdings in 2nd Quarter
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference,2016-09-07 20:19:02 +0000,http://www.publicnow.com/view/76F7250A5A1238B90FC40E8D6D11AF8FC2CE7ECA,"[at noodls] - DUBLIN, Sept. 7, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the Morgan Stanley Global Healthcare Conference ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Hottest Cancer Biotech Acquisition Targets After Medivation,2016-09-06 20:00:00 +0000,http://www.forbes.com/sites/kenkam/2016/09/06/3-hottest-cancer-biotech-acquisition-targets-after-medivation/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,3 Hottest Cancer Biotech Acquisition Targets After Medivation
JAZZ,JAZZ:UW,BBG000G9DVF3,Weakness Seen in Jazz Pharmaceuticals (JAZZ) Estimates: Should You Stay Away?,2016-08-29 14:15:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PrH2nStN_EQ/weakness-seen-in-jazz-pharmaceuticals-jazz-estimates-should-you-stay-away-cm671429,"Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to"
JAZZ,JAZZ:UW,BBG000G9DVF3,Weakness Seen in Jazz Pharmaceuticals (JAZZ) Estimates: Should You Stay Away?,2016-08-29 12:32:12 +0000,http://finance.yahoo.com/news/weakness-seen-jazz-pharmaceuticals-jazz-123212470.html,Weakness Seen in Jazz Pharmaceuticals (JAZZ) Estimates: Should You Stay Away?
JAZZ,JAZZ:UW,BBG000G9DVF3,Here Are All The Big Biotech Mergers In 2016,2016-08-27 22:36:10 +0000,http://finance.yahoo.com/news/big-biotech-mergers-2016-223610312.html,Here Are All The Big Biotech Mergers In 2016
JAZZ,JAZZ:UW,BBG000G9DVF3,Hedge Funds Are Obesely Overweight These 5 Mid-caps,2016-08-26 13:05:18 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-obesely-overweight-these-5-mid-caps-470283/,Hedge Funds Are Obesely Overweight These 5 Mid-caps
JAZZ,JAZZ:UW,BBG000G9DVF3,"Janney Initiates Jazz Pharma At Neutral, Cites Potential Competition For 'Blockbuster Narcolepsy Franchise'",2016-08-25 19:52:02 +0000,http://finance.yahoo.com/news/janney-initiates-jazz-pharma-neutral-195202490.html,"Janney Initiates Jazz Pharma At Neutral, Cites Potential Competition For 'Blockbuster Narcolepsy Franchise'"
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETF’s with exposure to Jazz Pharmaceuticals Plc : August 24, 2016",2016-08-24 16:03:42 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-jazz-pharmaceuticals-plc-august-24-2016/,"ETF’s with exposure to Jazz Pharmaceuticals Plc : August 24, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,Pfizer’s Medivation Acquisition: What You Need to Know,2016-08-23 13:04:05 +0000,http://marketrealist.com/2016/08/pfizers-medivation-acquisition-what-you-need-to-know/?utm_source=yahoo&utm_medium=feed,Pfizer’s Medivation Acquisition: What You Need to Know
JAZZ,JAZZ:UW,BBG000G9DVF3,PPH's Holdings Imply 16% Gain Potential,2016-08-22 13:42:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hQX31cVqYY4/pphs-holdings-imply-16-gain-potential-cm668287,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
JAZZ,JAZZ:UW,BBG000G9DVF3,4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer,2016-08-16 18:54:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MyXXrmZlDag/4-top-biotech-stocks-that-can-be-purchased-on-the-cheap-this-summer-cm665738,"Image source  Getty Images.  U.S stocks have been taken for a wild ride in 2016, but at least most long term investors can relish the fact that despite the volatility, the broader market"
JAZZ,JAZZ:UW,BBG000G9DVF3,4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer,2016-08-16 12:18:00 +0000,http://www.fool.com/investing/2016/08/16/4-top-biotech-stocks-that-can-be-purchased-on-the.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Top Biotech Stocks That Can Be Purchased on the Cheap This Summer
JAZZ,JAZZ:UW,BBG000G9DVF3,"ETF’s with exposure to Jazz Pharmaceuticals Plc : August 12, 2016",2016-08-12 18:29:50 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-jazz-pharmaceuticals-plc-august-12-2016/,"ETF’s with exposure to Jazz Pharmaceuticals Plc : August 12, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas,2016-08-12 12:25:46 +0000,http://247wallst.com/healthcare-business/2016/08/12/why-this-analyst-sees-huge-upside-for-valeant-and-2-more-specialty-pharmas/,Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Remains A Buy At Deutsche Bank Post Q2 Report,2016-08-11 19:04:08 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-remains-buy-deutsche-190408658.html,Jazz Pharmaceuticals Remains A Buy At Deutsche Bank Post Q2 Report
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016",2016-08-11 14:06:06 +0000,http://www.capitalcube.com/blog/index.php/jazz-pharmaceuticals-plc-jazz-us-earnings-analysis-q2-2016-by-the-numbers-august-11-2016/,"Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : August 11, 2016",2016-08-11 12:08:24 +0000,http://www.capitalcube.com/blog/index.php/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bearish-manner-jazz-us-august-11-2016/,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : August 11, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals (JAZZ) Stock Tumbles on Q2 Miss, Guidance",2016-08-10 19:37:00 +0000,https://www.thestreet.com/story/13671775/1/jazz-pharmaceuticals-jazz-stock-tumbles-on-q2-miss-guidance.html?puc=yahoo&cm_ven=YAHOO,"Jazz Pharmaceuticals (JAZZ) Stock Tumbles on Q2 Miss, Guidance"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Remains On Goldman's Buy List,2016-08-10 14:28:09 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-remains-goldmans-buy-142809636.html,Jazz Pharmaceuticals Remains On Goldman's Buy List
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz (JAZZ) Q2 Earnings Up Y/Y, Lowers Earnings Outlook",2016-08-10 13:28:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ebQzgMeQ8AU/jazz-jazz-q2-earnings-up-yy-lowers-earnings-outlook-cm663077,"Jazz Pharmaceuticals plcJAZZ reported second quarter 2016 earnings of $1.80 per share, up 28.6% from the year ago period. The Zacks Consensus Estimate was $1.71 per share. Excluding one time items, second quarter 2016 earnings increased 15.4% to $2.63"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz (JAZZ) Q2 Earnings Up Y/Y, Lowers Earnings Outlook",2016-08-10 11:55:11 +0000,http://finance.yahoo.com/news/jazz-jazz-q2-earnings-y-115511600.html,"Jazz (JAZZ) Q2 Earnings Up Y/Y, Lowers Earnings Outlook"
JAZZ,JAZZ:UW,BBG000G9DVF3,Edited Transcript of JAZZ earnings conference call or presentation 9-Aug-16 8:30pm GMT,2016-08-10 03:50:47 +0000,http://finance.yahoo.com/news/edited-transcript-jazz-earnings-conference-035047661.html,Edited Transcript of JAZZ earnings conference call or presentation 9-Aug-16 8:30pm GMT
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz misses Street 2Q forecasts,2016-08-09 22:11:07 +0000,http://sg.finance.yahoo.com/news/jazz-misses-street-2q-forecasts-221107963.html,Jazz misses Street 2Q forecasts
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Misses Earnings, Cuts Guidance",2016-08-09 20:22:05 +0000,http://finance.yahoo.com/news/jazz-pharmaceuticals-misses-earnings-cuts-202205416.html,"Jazz Pharmaceuticals Misses Earnings, Cuts Guidance"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Second Quarter 2016 Financial Results,2016-08-09 20:20:10 +0000,http://www.publicnow.com/view/326C5D1FC123554EED4C3C58BE018F9ACDC99A23,"[at noodls] - DUBLIN, Aug. 9, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2016 and updated financial guidance for 2016. ... This is an abstract ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and",2016-08-09 20:12:43 +0000,http://biz.yahoo.com/e/160809/jazz8-k.html,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Earnings Reaction History: Jazz Pharmaceuticals, Inc., 11.1% Follow-Through Indicator, 2.5% Sensitive",2016-08-09 19:33:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/doXc-8Cq-ZA/earnings-reaction-history-jazz-pharmaceuticals-inc-111-follow-through-indicator-25-sensitive-cm662758,"Expected Earnings Release 08 09 2016, After hours Avg. Extended Hours Dollar Volume $10,662,700 Jazz Pharmaceuticals, Inc. ( JAZZ ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can"
JAZZ,JAZZ:UW,BBG000G9DVF3,"After-Hours Earnings Report for August 9, 2016 :  DIS, MYL, MDVN, JAZZ, VSAT, TAHO, XON, DPLO, PCTY, FLTX, FSIC, WAGE",2016-08-09 19:11:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bxsqalmb0eo/after-hours-earnings-report-for-august-9-2016-dis-myl-mdvn-jazz-vsat-taho-xon-dplo-pcty-fltx-fsic-wage-cm662707,The following companies are expected to report earnings after hours on 08 09 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Walt Disney Company ( DIS ) is reporting for the
JAZZ,JAZZ:UW,BBG000G9DVF3,Q2 2016 Jazz Pharmaceuticals PLC Earnings Release - After Market Close,2016-08-09 11:07:03 +0000,http://biz.yahoo.com/research/earncal/20160809.html?t=jazz,Q2 2016 Jazz Pharmaceuticals PLC Earnings Release - After Market Close
JAZZ,JAZZ:UW,BBG000G9DVF3,4 Specialty Drugmakers Reporting Earnings Next Week,2016-08-06 12:53:11 +0000,http://www.investors.com/news/technology/4-specialty-drugmakers-reporting-earnings-next-week/,4 Specialty Drugmakers Reporting Earnings Next Week
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz (JAZZ) Q2 Earnings: Will the Stock Disappoint?,2016-08-05 13:59:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mf6K-gaXvkI/jazz-jazz-q2-earnings-will-the-stock-disappoint-cm660940,"Jazz Pharmaceuticals plcJAZZ is scheduled to report second quarter 2016 results on Aug 9, after the market closes . Last quarter, the company had comfortably surpassed expectations with a positive earnings surprise of 42.75%. Let's see how things have"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz (JAZZ) Q2 Earnings: Will the Stock Disappoint?,2016-08-05 11:45:11 +0000,http://finance.yahoo.com/news/jazz-jazz-q2-earnings-stock-114511623.html,Jazz (JAZZ) Q2 Earnings: Will the Stock Disappoint?
JAZZ,JAZZ:UW,BBG000G9DVF3,Hercules Announces Strong Second Quarter Financial Results with $ ...,2016-08-04 20:33:14 +0000,http://www.publicnow.com/view/0249D247DAB9029F3DEC1CCF5C71FD6874826906,"[at noodls] - Net Investment Income 'NII' Exceeds Dividend Payout at 103% Coverage Q2 2016 Financial Highlights $0.32 per share, or $23.4 million of Net Investment Income, an increase of 39.2% year-over-year $0.34 per ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,CMS Grants New Technology Add-On Payment to Defitelio for the Treatment of Hepatic Veno-Occlusive Disease with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation,2016-08-02 23:15:00 +0000,http://finance.yahoo.com/news/cms-grants-technology-add-payment-231500364.html,"[PR Newswire] - DUBLIN, Aug. 2, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Centers for Medicare and Medicaid Services (CMS) has granted a New Technology ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : July 29, 2016",2016-07-29 12:05:39 +0000,http://www.capitalcube.com/blog/index.php/jazz-pharmaceuticals-plc-breached-its-50-day-moving-average-in-a-bullish-manner-jazz-us-july-29-2016/,"Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : July 29, 2016"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies,2016-07-28 20:38:22 +0000,http://www.publicnow.com/view/1DCA44927801245E6DD425C09F8AA22D7DD97CF0,"[at noodls] - DUBLINand SAN DIEGO, July 28, 2016/PRNewswire / -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Pfenex Inc. (NYSE MKT: PFNX) today announced an agreement under which Pfenex granted Jazz Pharmaceuticals ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events",2016-07-28 10:18:45 +0000,http://biz.yahoo.com/e/160728/jazz8-k.html,"JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events"
JAZZ,JAZZ:UW,BBG000G9DVF3,Actinium Pharmaceuticals: Another Promising Name In The AML Space,2016-07-27 15:49:09 +0000,http://ir.baystreet.ca/article.aspx?id=255&1469634549,Actinium Pharmaceuticals: Another Promising Name In The AML Space
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9, 2016",2016-07-25 20:18:09 +0000,http://www.publicnow.com/view/064DEA43153534EC6595BB31D249A125C6B04CBF,"[at noodls] - DUBLIN, July 25, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 second quarter financial results on Tuesday, August 9, 2016, after the close of ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,This Could Be the Next Big Pharma Buyout,2016-07-18 19:13:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sERSuxc3jVg/this-could-be-the-next-big-pharma-buyout-cm650764,Photo source  Getty images.  Remember the days when the mindset of Big Pharma was to just do deals? It didn't matter what you did    you just had to do something.
JAZZ,JAZZ:UW,BBG000G9DVF3,Forget the Me-Too Cancer Drugs -- These Breakthroughs Are Where You Want to Invest,2016-07-17 19:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lbChnGP2j4g/forget-the-me-too-cancer-drugs-these-breakthroughs-are-where-you-want-to-invest-cm650271,"Image source  Getty Images.  The most powerful man in the field of cancer treatment, FDA oncology chief Dr. Richard Pazdur, recently gave some excellent business advice to drugmakers that applies equally well to"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celator Pharmaceuticals, Inc.",2016-07-12 06:03:04 +0000,http://www.publicnow.com/view/1A6E177C7ECA213AB1DEAC77755BA48745DD87E4,"[at noodls] - DUBLIN, July 12, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the results of its tender offer to purchase all of the outstanding shares of common stock of Celator Pharmaceuticals, ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,JAZZ August 26th Options Begin Trading,2016-07-07 16:37:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QFTevQpL2Wk/jazz-august-26th-options-begin-trading-cm645862,"Investors in Jazz Pharmaceuticals plc (Symbol JAZZ) saw new options become available today, for the August 26th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the JAZZ options chain for the new August"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Why Celator Pharmaceuticals Is Up 1,610% in 2016",2016-06-27 14:32:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AjF8g-UppXY/why-celator-pharmaceuticals-is-up-1610-in-2016-cm641173,"Image source  Getty Images.  What  Shares of Celator Pharmaceuticals (NASDAQ  CPXX) , a clinical stage oncology focused biopharmaceutical company, have rocketed 1,610% higher year to date, according to data from S&P Global Market"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition",2016-06-27 04:20:04 +0000,http://www.publicnow.com/view/0D8B2C988C9BFD3E6E86DDB352F035F0B075A6A8,"[at noodls] - DUBLIN, June 27, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ('HSR'), with ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Interesting JAZZ Put And Call Options For August 5th,2016-06-23 16:57:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qNHg9deVsaY/interesting-jazz-put-and-call-options-for-august-5th-cm639673,"Investors in Jazz Pharmaceuticals plc (Symbol JAZZ) saw new options begin trading today, for the August 5th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the JAZZ options chain for the new August"
JAZZ,JAZZ:UW,BBG000G9DVF3,First Week of August 19th Options Trading For Jazz Pharmaceuticals (JAZZ),2016-06-21 16:02:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bogzqvhJ35k/first-week-of-august-19th-options-trading-for-jazz-pharmaceuticals-jazz-cm638458,"Investors in Jazz Pharmaceuticals plc (Symbol JAZZ) saw new options begin trading this week, for the August 19th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the JAZZ options chain for the new"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Offers HAL Study Data on JZP-110,2016-06-15 16:09:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WxehGD_u8Lw/jazz-pharmaceuticals-offers-hal-study-data-on-jzp-110-cm635860,"Jazz Pharmaceuticals Public Limited CompanyJAZZ presented new data from a Human Abuse Liability (HAL) study on its investigational wake promoting agent, JZP 110, at the annual meeting of the Associated Professional Sleep Societies (APSS). JZP 110 is currently in"
JAZZ,JAZZ:UW,BBG000G9DVF3,4 Cancer Drug Developers You Need to Have on Your Radar This Year,2016-06-15 14:05:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W33nfjCRXMs/4-cancer-drug-developers-you-need-to-have-on-your-radar-this-year-cm635668,"Image source  Getty Images.  Global spending on cancer medicines topped $107 billion last year, and is expected to reach $150 billion by 2020. Over the past decade our understanding of how different cancers evade"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Conference Call and Webcast for JZP-110 Investor Update,2016-06-14 20:19:01 +0000,http://www.publicnow.com/view/8BC76CE9202D5F2CA2E8D3836C602447B51FC3D4,"[at noodls] - DUBLIN, June 14, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it is hosting an investor conference call and audio webcast on Monday, June 20, 2016 at 4:30 p.m. EDT/9:30 ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Notable ETF Outflow Detected - XPH, RLYP, AKRX, JAZZ",2016-06-14 16:07:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BsuJWCjvPmU/notable-etf-outflow-detected-xph-rlyp-akrx-jazz-cm635159,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P Pharmaceuticals ETF (Symbol XPH) where we have detected an approximate $79.8 million dollar outflow"
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals Presents New Data from a Human Abuse Liability (HAL) Study for JZP-110, an Investigational Treatment for Excessive Sleepiness in Patients with Narcolepsy or with Obstructive Sleep Apnea, at 30th Annual SLEEP Meeting",2016-06-14 13:19:09 +0000,http://www.publicnow.com/view/5106F351D0356D144724ABD7CA67390D385F2180,"[at noodls] - DUBLIN, June 14, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced results from a Human Abuse Liability (HAL) study of JZP-110, an investigational wake-promoting agent in Phase ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Sum Up The Parts: PXMG Could Be Worth $34,2016-06-14 13:07:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fGQExBOep_w/sum-up-the-parts-pxmg-could-be-worth-34-cm634937,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
JAZZ,JAZZ:UW,BBG000G9DVF3,3 Cheap Biotech Stocks You Can Buy Now,2016-06-06 16:10:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rUpKOWYOSV0/3-cheap-biotech-stocks-you-can-buy-now-cm630934,"With biotechnology stocks regaining some of their luster lately, some investors may be hunting for bargains to stash away in their long term portfolios. If you're among them, we've got you covered. Here are three"
JAZZ,JAZZ:UW,BBG000G9DVF3,Celator Pharmaceuticals Remains Sharply Higher On Takeover,2016-05-31 12:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NwEGCDTay5M/celator-pharmaceuticals-remains-sharply-higher-on-takeover-20160531-00841,Celator Pharmaceuticals Remains Sharply Higher On Takeover
JAZZ,JAZZ:UW,BBG000G9DVF3,Celator Pharmaceuticals Inc. (CPXX) Has Soared To A New High After Merger,2016-05-31 09:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hxqR-5ra8XI/celator-pharmaceuticals-inc-cpxx-has-soared-to-a-new-high-after-merger-20160531-00643,Celator Pharmaceuticals Inc. (CPXX) Has Soared To A New High After Merger
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma to buy Celator in $1.5 billion deal,2016-05-31 09:02:20 +0000,http://sg.finance.yahoo.com/news/jazz-pharma-buy-celator-1-080728521.html,Jazz Pharma to buy Celator in $1.5 billion deal
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share,2016-05-31 07:42:04 +0000,http://www.publicnow.com/view/51B321544623773758305A8BC34A3A4F8B08C64D,"[at noodls] - www.jazzpharmaceuticals.com. About Celator Pharmaceuticals, Inc. ... This is an abstract of the original noodl. To continue reading this document, click here for the original version."
JAZZ,JAZZ:UW,BBG000G9DVF3,CPXX Investors Laughing All The Way To The Bank...,2016-05-31 06:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4sprbJ34F50/cpxx-investors-laughing-all-the-way-to-the-bank-20160531-00144,CPXX Investors Laughing All The Way To The Bank...
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion,2016-05-31 05:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kA0BCA7hZPs/jazz-pharmaceuticals-agrees-to-buy-celator-for-about-15-billion-20160531-00102,Jazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ,2016-05-31 04:00:33 +0000,http://sg.finance.yahoo.com/news/jazz-pharma-nears-deal-buy-040033391.html,Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharma To Buy Celator For $1.5 Bln - Quick Facts,2016-05-31 03:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HMYYvXOi1kE/jazz-pharma-to-buy-celator-for-15-bln--quick-facts-20160531-00059,Jazz Pharma To Buy Celator For $1.5 Bln - Quick Facts
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion,2016-05-30 22:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UX8N2qOOXvE/jazz-pharmaceuticals-nears-deal-to-buy-celator-for-about-15-billion-20160530-00254,Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion
JAZZ,JAZZ:UW,BBG000G9DVF3,Correction to Jazz Pharmaceuticals Story,2016-05-30 22:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EzCDuOOkfdk/correction-to-jazz-pharmaceuticals-story-20160530-00253,Correction to Jazz Pharmaceuticals Story
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences,2016-05-18 20:12:04 +0000,http://www.publicnow.com/view/15E7CE3C52B09BF1147E094646AC90D62D41DD89,"[at noodls] - DUBLIN, May 18, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences. UBS Global ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz misses Street 1Q forecasts,2016-05-10 21:16:39 +0000,http://sg.finance.yahoo.com/news/jazz-misses-street-1q-forecasts-211639483.html,Jazz misses Street 1Q forecasts
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces First Quarter 2016 Financial Results,2016-05-10 20:18:07 +0000,http://www.publicnow.com/view/5E543CF65517AF44CAA7FB3BAF6EE1534EABD8C0,"[at noodls] - DUBLIN, May 10, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2016 and updated financial guidance for 2016. ... This is an abstract ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016",2016-04-26 20:14:51 +0000,http://www.publicnow.com/view/93EBA5D96C03A6B78A4CED08B023339E1874BA8E,"[at noodls] - DUBLIN, April 26, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 first quarter financial results on Tuesday, May 10, 2016, after the close of ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Webcast for Defitelio® (defibrotide sodium) Investor Update,2016-03-30 19:09:13 +0000,http://www.publicnow.com/view/D7F1BD03B1310E6B53BE3E2629DDA2C0AB78E382,"[at noodls] - DUBLIN, March 30, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Thursday, March 31, 2016 at 4:30 p.m. EDT/9:30 p.m. IST to provide ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT),2016-03-30 18:47:36 +0000,http://www.publicnow.com/view/09576EA17E92BA36CF6CE049687E12488CF423CD,"[at noodls] - DUBLIN, March 30, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Food and Drug Administration (FDA) granted marketing approval for Defitelio ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz beats 4Q profit forecasts,2016-02-23 22:47:26 +0000,http://sg.finance.yahoo.com/news/jazz-beats-4q-profit-forecasts-224726561.html,Jazz beats 4Q profit forecasts
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 11,2016-01-04 21:20:10 +0000,http://www.noodls.com/view/F80BF65971AE00B95CCFF71CDB6FD947B3E60F54,"[at noodls] - , /PRNewswire/ -- (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 34 Annual in , chairman and chief executive officer, will provide an overview of the ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz misses Street 3Q forecasts,2015-11-10 00:09:48 +0000,http://sg.finance.yahoo.com/news/jazz-misses-street-3q-forecasts-000948843.html,Jazz misses Street 3Q forecasts
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Third Quarter 2015 Financial Results,2015-11-09 21:26:19 +0000,http://www.noodls.com/view/B9708621203CB44DB9B2B744E04ED9421E9B6E5D,"[at noodls] - DUBLIN, Nov. 9, 2015 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2015 and updated financial guidance for 2015. ... This is an abstract ..."
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences,2015-11-04 21:38:17 +0000,http://www.noodls.com/view/61ABF71C74DA59F9CB9E915988C007770B635720,[at noodls] - Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences
JAZZ,JAZZ:UW,BBG000G9DVF3,"Jazz Pharmaceuticals to Report 2015 Third Quarter Financial Results on November 9, 2015",2015-10-26 20:25:10 +0000,http://www.noodls.com/view/3A834C78076BA74946EF26AE40E603AFE2A5D61D,"[at noodls] - Jazz Pharmaceuticals to Report 2015 Third Quarter Financial Results on November 9, 2015"
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz meets 2Q profit forecasts,2015-08-05 21:39:51 +0000,http://sg.finance.yahoo.com/news/jazz-meets-2q-profit-forecasts-213951259.html,Jazz meets 2Q profit forecasts
JAZZ,JAZZ:UW,BBG000G9DVF3,Jazz tops Street 4Q forecasts,2015-02-25 00:09:55 +0000,http://sg.finance.yahoo.com/news/jazz-tops-street-4q-forecasts-000955672.html,Jazz tops Street 4Q forecasts
